CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: vanadium group element atom
Accession: CHEBI:33347
browse the term
Synonyms: exact_synonym: group 5 elements
related_synonym: vanadium group element; vanadium group elements
G
ABCC5
ATP binding cassette subfamily C member 5
affects expression
ISO
vanadium pentoxide affects the expression of ABCC5 mRNA
CTD
PMID:26210822
NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939
G
ADCY2
adenylate cyclase 2
affects expression
ISO
vanadium pentoxide affects the expression of ADCY2 mRNA
CTD
PMID:26210822
NCBI chr 5:7,396,138...7,830,081
Ensembl chr 5:7,396,138...7,830,081
G
ADCY3
adenylate cyclase 3
affects expression
ISO
vanadium pentoxide affects the expression of ADCY3 mRNA
CTD
PMID:26210822
NCBI chr 2:24,819,169...24,920,237
Ensembl chr 2:24,819,169...24,920,237
G
ADCY4
adenylate cyclase 4
affects expression
ISO
vanadium pentoxide affects the expression of ADCY4 mRNA
CTD
PMID:26210822
NCBI chr14:24,318,359...24,335,071
Ensembl chr14:24,318,349...24,335,093
G
ADCY7
adenylate cyclase 7
affects expression
ISO
vanadium pentoxide affects the expression of ADCY7 mRNA
CTD
PMID:26210822
NCBI chr16:50,244,699...50,318,135
Ensembl chr16:50,246,137...50,318,135
G
ADCY8
adenylate cyclase 8
affects expression
ISO
vanadium pentoxide affects the expression of ADCY8 mRNA
CTD
PMID:26210822
NCBI chr 8:130,780,301...131,040,909
Ensembl chr 8:130,780,301...131,040,909
G
ARSJ
arylsulfatase family member J
affects expression
ISO
vanadium pentoxide affects the expression of ARSJ mRNA
CTD
PMID:26210822
NCBI chr 4:113,900,284...113,979,647
Ensembl chr 4:113,900,284...113,979,727
G
BMP2
bone morphogenetic protein 2
affects expression
EXP
vanadium pentoxide affects the expression of BMP2 mRNA
CTD
PMID:17459161
NCBI chr20:6,767,686...6,780,246
Ensembl chr20:6,767,686...6,780,246
G
BTG1
BTG anti-proliferation factor 1
decreases expression
EXP
vanadium pentoxide results in decreased expression of BTG1 mRNA
CTD
PMID:17459161
NCBI chr12:92,140,278...92,145,846
Ensembl chr12:92,140,278...92,145,846
G
BTG2
BTG anti-proliferation factor 2
decreases expression
EXP
vanadium pentoxide results in decreased expression of BTG2 mRNA
CTD
PMID:17459161
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
G
CASP3
caspase 3
multiple interactions increases activity
ISO
PRKCD mutant form inhibits the reaction [vanadium pentoxide results in increased activity of CASP3 protein]
CTD
PMID:19646462
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP9
caspase 9
increases activity
ISO
vanadium pentoxide results in increased activity of CASP9 protein
CTD
PMID:19646462
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CCL8
C-C motif chemokine ligand 8
increases expression
EXP
vanadium pentoxide results in increased expression of CCL8 mRNA
CTD
PMID:17459161
NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402
G
CCN2
cellular communication network factor 2
decreases expression
EXP
vanadium pentoxide results in decreased expression of CCN2 mRNA
CTD
PMID:17459161
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CCNG2
cyclin G2
decreases expression
EXP
vanadium pentoxide results in decreased expression of CCNG2 mRNA
CTD
PMID:17459161
NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388
G
CCNT2
cyclin T2
affects expression
EXP
vanadium pentoxide affects the expression of CCNT2 mRNA
CTD
PMID:17459161
NCBI chr 2:134,918,822...134,959,342
Ensembl chr 2:134,918,235...134,959,342
G
CD44
CD44 molecule (Indian blood group)
affects expression
EXP ISO
vanadium pentoxide affects the expression of CD44 mRNA
CTD
PMID:17459161 PMID:26210822
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
G
CDC25C
cell division cycle 25C
increases expression
EXP
vanadium pentoxide results in increased expression of CDC25C protein
CTD
PMID:33913241
NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355
G
CDK7
cyclin dependent kinase 7
decreases expression
EXP
vanadium pentoxide results in decreased expression of CDK7 mRNA
CTD
PMID:17459161
NCBI chr 5:69,234,795...69,277,430
Ensembl chr 5:69,234,795...69,277,430
G
CDK9
cyclin dependent kinase 9
decreases expression
EXP
vanadium pentoxide results in decreased expression of CDK9 mRNA
CTD
PMID:17459161
NCBI chr 9:127,786,034...127,790,792
Ensembl chr 9:127,785,679...127,790,792
G
CDKN1A
cyclin dependent kinase inhibitor 1A
decreases expression
EXP
vanadium pentoxide results in decreased expression of CDKN1A protein
CTD
PMID:33913241
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN1B
cyclin dependent kinase inhibitor 1B
decreases expression
EXP
vanadium pentoxide results in decreased expression of CDKN1B mRNA
CTD
PMID:17459161
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CDKN1C
cyclin dependent kinase inhibitor 1C
decreases expression
EXP
vanadium pentoxide results in decreased expression of CDKN1C mRNA
CTD
PMID:17459161
NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775
G
CDKN2C
cyclin dependent kinase inhibitor 2C
decreases expression
EXP
vanadium pentoxide results in decreased expression of CDKN2C mRNA
CTD
PMID:17459161
NCBI chr 1:50,968,706...50,974,634
Ensembl chr 1:50,960,745...50,974,634
G
COL1A1
collagen type I alpha 1 chain
decreases expression
EXP
vanadium pentoxide results in decreased expression of COL1A1 mRNA
CTD
PMID:17459161
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL1A2
collagen type I alpha 2 chain
decreases expression
EXP
vanadium pentoxide results in decreased expression of COL1A2 mRNA
CTD
PMID:17459161
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
G
COL3A1
collagen type III alpha 1 chain
decreases expression
EXP
vanadium pentoxide results in decreased expression of COL3A1 mRNA
CTD
PMID:17459161
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
G
CTSA
cathepsin A
affects expression
ISO
vanadium pentoxide affects the expression of CTSA mRNA
CTD
PMID:26210822
NCBI chr20:45,891,335...45,898,820
Ensembl chr20:45,890,144...45,898,949
G
CX3CR1
C-X3-C motif chemokine receptor 1
increases expression
EXP
vanadium pentoxide results in increased expression of CX3CR1 mRNA
CTD
PMID:17459161
NCBI chr 3:39,263,494...39,292,966
Ensembl chr 3:39,263,495...39,281,735
G
CXCL1
C-X-C motif chemokine ligand 1
increases expression
ISO
vanadium pentoxide results in increased expression of CXCL1 protein
CTD
PMID:9707512
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
multiple interactions increases expression
EXP
acetovanillone inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA]; Allopurinol inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA]
CTD
PMID:17459161 PMID:18322232
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL2
C-X-C motif chemokine ligand 2
increases expression
ISO
vanadium pentoxide results in increased expression of CXCL2 protein
CTD
PMID:9707512
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL8
C-X-C motif chemokine ligand 8
multiple interactions increases expression
EXP
Acetylcysteine inhibits the reaction [vanadium pentoxide results in increased expression of CXCL8 protein]; tetramethylthiourea inhibits the reaction [vanadium pentoxide results in increased expression of CXCL8 protein] vanadium pentoxide results in increased expression of CXCL8 mRNA; vanadium pentoxide results in increased expression of CXCL8 protein
CTD
PMID:9707512 PMID:17459161
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCL9
C-X-C motif chemokine ligand 9
increases expression
EXP
vanadium pentoxide results in increased expression of CXCL9 mRNA
CTD
PMID:17459161
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
DUSP6
dual specificity phosphatase 6
affects expression
EXP
vanadium pentoxide affects the expression of DUSP6 mRNA
CTD
PMID:17459161
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
EGR1
early growth response 1
affects expression
EXP
vanadium pentoxide affects the expression of EGR1 mRNA
CTD
PMID:17459161
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EGR3
early growth response 3
affects expression
EXP
vanadium pentoxide affects the expression of EGR3 mRNA
CTD
PMID:17459161
NCBI chr 8:22,687,659...22,693,480
Ensembl chr 8:22,687,659...22,693,480
G
FABP4
fatty acid binding protein 4
decreases expression
ISO
vanadium pentoxide results in decreased expression of FABP4 mRNA
CTD
PMID:26210822
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
G
FGF2
fibroblast growth factor 2
decreases expression
EXP
vanadium pentoxide results in decreased expression of FGF2 mRNA
CTD
PMID:17459161
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
FGF9
fibroblast growth factor 9
decreases expression
EXP
vanadium pentoxide results in decreased expression of FGF9 mRNA
CTD
PMID:17459161
NCBI chr13:21,671,073...21,704,498
Ensembl chr13:21,671,073...21,704,498
G
GALC
galactosylceramidase
affects expression
ISO
vanadium pentoxide affects the expression of GALC mRNA
CTD
PMID:26210822
NCBI chr14:87,933,014...87,993,665
Ensembl chr14:87,837,820...87,993,665
G
GAS1
growth arrest specific 1
decreases expression
EXP
vanadium pentoxide results in decreased expression of GAS1 mRNA
CTD
PMID:17459161
NCBI chr 9:86,944,362...86,947,506
Ensembl chr 9:86,944,362...86,947,506
G
GATA6
GATA binding protein 6
affects expression
EXP
vanadium pentoxide affects the expression of GATA6 mRNA
CTD
PMID:17459161
NCBI chr18:22,169,589...22,202,528
Ensembl chr18:22,169,589...22,202,528
G
GBP1
guanylate binding protein 1
affects expression
EXP
vanadium pentoxide affects the expression of GBP1 mRNA
CTD
PMID:17459161
NCBI chr 1:89,052,319...89,065,208
Ensembl chr 1:89,051,882...89,065,360
G
GDF15
growth differentiation factor 15
increases expression
EXP
vanadium pentoxide results in increased expression of GDF15 mRNA
CTD
PMID:17459161
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GUSB
glucuronidase beta
affects expression
ISO
vanadium pentoxide affects the expression of GUSB mRNA
CTD
PMID:26210822
NCBI chr 7:65,960,684...65,982,213
Ensembl chr 7:65,960,684...65,982,215
G
HBEGF
heparin binding EGF like growth factor
multiple interactions increases expression
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [vanadium pentoxide results in increased expression of HBEGF mRNA]; Acetylcysteine inhibits the reaction [vanadium pentoxide results in increased expression of HBEGF mRNA]; RTKI cpd inhibits the reaction [vanadium pentoxide results in increased expression of HBEGF mRNA]; SB 203580 inhibits the reaction [vanadium pentoxide results in increased expression of HBEGF mRNA] vanadium pentoxide results in increased expression of HBEGF mRNA; vanadium pentoxide results in increased expression of HBEGF protein
CTD
PMID:11159045 PMID:12676768 PMID:17459161
NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
G
HEXA
hexosaminidase subunit alpha
affects expression
ISO
vanadium pentoxide affects the expression of HEXA mRNA
CTD
PMID:26210822
NCBI chr15:72,340,924...72,376,014
Ensembl chr15:72,340,924...72,376,420
G
HGF
hepatocyte growth factor
increases expression
EXP
vanadium pentoxide results in increased expression of HGF mRNA
CTD
PMID:17459161
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
HYAL2
hyaluronidase 2
affects expression
ISO
vanadium pentoxide affects the expression of HYAL2 mRNA
CTD
PMID:26210822
NCBI chr 3:50,317,808...50,322,745
Ensembl chr 3:50,317,790...50,322,782
G
IFNB1
interferon beta 1
multiple interactions increases expression
EXP
acetovanillone inhibits the reaction [vanadium pentoxide results in increased expression of IFNB1 mRNA]; Allopurinol inhibits the reaction [vanadium pentoxide results in increased expression of IFNB1 mRNA]; IFNB1 protein affects the reaction [vanadium pentoxide results in increased activity of STAT1 protein]
CTD
PMID:18322232
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
G
IFNGR1
interferon gamma receptor 1
decreases expression
EXP
vanadium pentoxide results in decreased expression of IFNGR1 mRNA
CTD
PMID:17459161
NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449
G
IL15
interleukin 15
decreases expression
EXP
vanadium pentoxide results in decreased expression of IL15 mRNA
CTD
PMID:17459161
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL6
interleukin 6
increases expression
EXP
vanadium pentoxide results in increased expression of IL6 mRNA
CTD
PMID:17459161
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IRF1
interferon regulatory factor 1
affects expression
EXP
vanadium pentoxide affects the expression of IRF1 mRNA
CTD
PMID:17459161
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
G
JAK1
Janus kinase 1
multiple interactions
EXP
JAK1 protein affects the reaction [vanadium pentoxide results in increased activity of STAT1 protein]
CTD
PMID:18322232
NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,223...65,067,754
G
JAK2
Janus kinase 2
decreases expression
EXP
vanadium pentoxide results in decreased expression of JAK2 mRNA
CTD
PMID:17459161
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
vanadium pentoxide results in increased expression of JUN mRNA
CTD
PMID:17459161
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KEAP1
kelch like ECH associated protein 1
decreases expression
EXP
vanadium pentoxide results in decreased expression of KEAP1 mRNA
CTD
PMID:17459161
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
G
KLF7
KLF transcription factor 7
increases expression
EXP
vanadium pentoxide results in increased expression of KLF7 mRNA
CTD
PMID:17459161
NCBI chr 2:207,074,137...207,173,851
Ensembl chr 2:207,074,137...207,173,856
G
LYST
lysosomal trafficking regulator
affects expression
EXP
vanadium pentoxide affects the expression of LYST mRNA
CTD
PMID:17459161
NCBI chr 1:235,661,031...235,883,713
Ensembl chr 1:235,661,041...235,883,724
G
LYVE1
lymphatic vessel endothelial hyaluronan receptor 1
affects expression
ISO
vanadium pentoxide affects the expression of LYVE1 mRNA
CTD
PMID:26210822
NCBI chr11:10,556,966...10,568,665
Ensembl chr11:10,556,966...10,611,689
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation increases activity
ISO EXP
vanadium pentoxide results in increased phosphorylation of MAPK1 protein vanadium pentoxide results in increased activity of MAPK1 protein
CTD
PMID:12376484 PMID:12676768
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
increases phosphorylation increases activity
ISO EXP
vanadium pentoxide results in increased phosphorylation of MAPK3 protein vanadium pentoxide results in increased activity of MAPK3 protein
CTD
PMID:12376484 PMID:12676768
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MARCKS
myristoylated alanine rich protein kinase C substrate
decreases expression
EXP
vanadium pentoxide results in decreased expression of MARCKS mRNA
CTD
PMID:17459161
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
G
MMP2
matrix metallopeptidase 2
increases expression
ISO
vanadium pentoxide results in increased expression of MMP2 protein
CTD
PMID:18059072
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
increases expression
ISO
vanadium pentoxide results in increased expression of MMP9 protein
CTD
PMID:18059072
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MTCH1
mitochondrial carrier 1
affects expression
ISO
vanadium pentoxide affects the expression of MTCH1 mRNA
CTD
PMID:26210822
NCBI chr 6:36,968,135...36,986,551
Ensembl chr 6:36,965,807...36,986,298
G
NAMPT
nicotinamide phosphoribosyltransferase
increases expression
EXP
vanadium pentoxide results in increased expression of NAMPT mRNA
CTD
PMID:17459161
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
G
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
affects expression
EXP
vanadium pentoxide affects the expression of NEDD9 mRNA
CTD
PMID:17459161
NCBI chr 6:11,183,298...11,382,348
Ensembl chr 6:11,183,298...11,382,348
G
NEURL1
neuralized E3 ubiquitin protein ligase 1
affects expression
ISO
vanadium pentoxide affects the expression of NEURL1A mRNA
CTD
PMID:26210822
NCBI chr10:103,493,705...103,592,546
Ensembl chr10:103,493,705...103,592,546
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
vanadium pentoxide results in increased expression of NQO1 mRNA
CTD
PMID:17459161
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
OXR1
oxidation resistance 1
decreases expression
EXP
vanadium pentoxide results in decreased expression of OXR1 mRNA
CTD
PMID:17459161
NCBI chr 8:106,270,178...106,752,694
Ensembl chr 8:106,270,144...106,752,694
G
OXSR1
oxidative stress responsive kinase 1
decreases expression
EXP
vanadium pentoxide results in decreased expression of OXSR1 mRNA
CTD
PMID:17459161
NCBI chr 3:38,164,063...38,255,484
Ensembl chr 3:38,165,089...38,255,484
G
PDGFA
platelet derived growth factor subunit A
increases expression
ISO
vanadium pentoxide results in increased expression of PDGFA mRNA
CTD
PMID:17134509
NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296
G
PDGFB
platelet derived growth factor subunit B
increases expression
ISO
vanadium pentoxide results in increased expression of PDGFB mRNA
CTD
PMID:17134509
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PDGFC
platelet derived growth factor C
increases expression
ISO
vanadium pentoxide results in increased expression of PDGFC mRNA
CTD
PMID:17134509
NCBI chr 4:156,760,454...156,971,799
Ensembl chr 4:156,760,454...156,971,799
G
PDGFRA
platelet derived growth factor receptor alpha
increases expression
ISO
vanadium pentoxide results in increased expression of PDGFRA mRNA
CTD
PMID:17134509
NCBI chr 4:54,229,293...54,298,245
Ensembl chr 4:54,229,280...54,298,245
G
PIPOX
pipecolic acid and sarcosine oxidase
increases expression
EXP
vanadium pentoxide results in increased expression of PIPOX mRNA
CTD
PMID:17459161
NCBI chr17:29,043,141...29,057,216
Ensembl chr17:28,950,513...29,057,216
G
PLPP1
phospholipid phosphatase 1
affects expression
ISO
vanadium pentoxide affects the expression of PPAP2A mRNA
CTD
PMID:26210822
NCBI chr 5:55,424,854...55,534,964
Ensembl chr 5:55,424,854...55,534,969
G
PLPP3
phospholipid phosphatase 3
affects expression
ISO
vanadium pentoxide affects the expression of PLPP3 mRNA
CTD
PMID:26210822
NCBI chr 1:56,494,761...56,579,563
Ensembl chr 1:56,494,761...56,645,301
G
PRKCD
protein kinase C delta
multiple interactions increases expression
ISO
PRKCD mutant form inhibits the reaction [vanadium pentoxide results in increased activity of CASP3 protein]; vanadium pentoxide results in increased cleavage of and results in increased activity of PRKCD protein vanadium pentoxide results in increased expression of PRKCD mRNA
CTD
PMID:19646462 PMID:26210822
NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
G
PRKCE
protein kinase C epsilon
affects expression
ISO
vanadium pentoxide affects the expression of PRKCE mRNA
CTD
PMID:26210822
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
G
SGPL1
sphingosine-1-phosphate lyase 1
affects expression
ISO
vanadium pentoxide affects the expression of SGPL1 mRNA
CTD
PMID:26210822
NCBI chr10:70,815,948...70,881,184
Ensembl chr10:70,815,905...70,895,816
G
SLC11A2
solute carrier family 11 member 2
increases expression
ISO
vanadium pentoxide results in increased expression of SLC11A2 protein
CTD
PMID:19646462
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
G
SLC2A3
solute carrier family 2 member 3
affects expression
EXP
vanadium pentoxide affects the expression of SLC2A3 mRNA
CTD
PMID:17459161
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
G
SLC2A4
solute carrier family 2 member 4
decreases expression
ISO
vanadium pentoxide results in decreased expression of SLC2A4 mRNA
CTD
PMID:26210822
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
G
SMAD1
SMAD family member 1
decreases expression
EXP
vanadium pentoxide results in decreased expression of SMAD1 mRNA
CTD
PMID:17459161
NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176
G
SMURF1
SMAD specific E3 ubiquitin protein ligase 1
decreases expression
EXP
vanadium pentoxide results in decreased expression of SMURF1 mRNA
CTD
PMID:17459161
NCBI chr 7:99,027,440...99,144,108
Ensembl chr 7:99,027,440...99,144,108
G
SOCS1
suppressor of cytokine signaling 1
decreases expression
EXP
vanadium pentoxide results in decreased expression of SOCS1 mRNA
CTD
PMID:17459161
NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
G
SOCS3
suppressor of cytokine signaling 3
increases expression
EXP
vanadium pentoxide results in increased expression of SOCS3 mRNA
CTD
PMID:17459161
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
G
SOD2
superoxide dismutase 2
increases expression
EXP
vanadium pentoxide results in increased expression of SOD2 mRNA
CTD
PMID:17459161
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SPHK1
sphingosine kinase 1
affects expression
ISO
vanadium pentoxide affects the expression of SPHK1 mRNA
CTD
PMID:26210822
NCBI chr17:76,383,204...76,387,855
Ensembl chr17:76,376,584...76,387,860
G
SPP1
secreted phosphoprotein 1
increases expression
ISO
vanadium pentoxide results in increased expression of SPP1 mRNA
CTD
PMID:17134509
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SPRED2
sprouty related EVH1 domain containing 2
affects expression
EXP
vanadium pentoxide affects the expression of SPRED2 mRNA
CTD
PMID:17459161
NCBI chr 2:65,307,175...65,432,599
Ensembl chr 2:65,310,851...65,432,637
G
SPTLC2
serine palmitoyltransferase long chain base subunit 2
affects expression
ISO
vanadium pentoxide affects the expression of SPTLC2 mRNA
CTD
PMID:26210822
NCBI chr14:77,505,997...77,616,637
Ensembl chr14:77,505,997...77,616,637
G
STAT1
signal transducer and activator of transcription 1
multiple interactions decreases expression
EXP
acetovanillone inhibits the reaction [vanadium pentoxide results in increased phosphorylation of STAT1 protein]; Allopurinol inhibits the reaction [vanadium pentoxide results in increased phosphorylation of STAT1 protein]; Hydrogen Peroxide affects the reaction [vanadium pentoxide results in increased phosphorylation of and results in increased activity of STAT1 protein]; IFNB1 protein affects the reaction [vanadium pentoxide results in increased activity of STAT1 protein]; JAK1 protein affects the reaction [vanadium pentoxide results in increased activity of STAT1 protein]; vanadium pentoxide results in increased activity of and results in increased phosphorylation of STAT1 protein vanadium pentoxide results in decreased expression of STAT1 mRNA
CTD
PMID:17459161 PMID:18322232
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
STC1
stanniocalcin 1
increases expression
EXP
vanadium pentoxide results in increased expression of STC1 mRNA
CTD
PMID:17459161
NCBI chr 8:23,841,929...23,854,806
Ensembl chr 8:23,841,929...23,854,806
G
TF
transferrin
increases expression
ISO
vanadium pentoxide results in increased expression of TF protein
CTD
PMID:19646462
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
G
TGFB2
transforming growth factor beta 2
decreases expression
EXP
vanadium pentoxide results in decreased expression of TGFB2 mRNA
CTD
PMID:17459161
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
G
TNF
tumor necrosis factor
increases expression
EXP
vanadium pentoxide results in increased expression of TNF protein
CTD
PMID:9707512
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TRAF4
TNF receptor associated factor 4
decreases expression
EXP
vanadium pentoxide results in decreased expression of TRAF4 mRNA
CTD
PMID:17459161
NCBI chr17:28,744,011...28,750,956
Ensembl chr17:28,744,011...28,750,956
G
UCP1
uncoupling protein 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of UCP1 mRNA
CTD
PMID:26210822
NCBI chr 4:140,559,431...140,568,961
Ensembl chr 4:140,559,431...140,568,961
G
VCAM1
vascular cell adhesion molecule 1
decreases expression
EXP
vanadium pentoxide results in decreased expression of VCAM1 mRNA
CTD
PMID:17459161
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
G
VEGFA
vascular endothelial growth factor A
increases expression
EXP
vanadium pentoxide results in increased expression of VEGFA mRNA
CTD
PMID:17459161
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
SLC6A4
solute carrier family 6 member 4
increases activity
ISO
sodium vanadate increases activity of Slc6a4 protein in synaptosomes trisodium vanadate increases activity of Slc6a4 protein in cultured neurons
RGD
PMID:12590935 PMID:11859926
RGD:38549585 , RGD:38549589
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
increases expression
EXP
Vanadium results in increased expression of ABL1 mRNA
CTD
PMID:19000753
NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,043...130,887,675
G
ACO1
aconitase 1
increases activity
EXP
Vanadium results in increased activity of ACO1 protein
CTD
PMID:16386771
NCBI chr 9:32,384,643...32,454,769
Ensembl chr 9:32,384,603...32,454,769
G
ADAM17
ADAM metallopeptidase domain 17
increases expression
EXP
Vanadium results in increased expression of ADAM17 mRNA
CTD
PMID:19000753
NCBI chr 2:9,488,486...9,555,830
Ensembl chr 2:9,488,486...9,556,732
G
ADAMTS4
ADAM metallopeptidase with thrombospondin type 1 motif 4
decreases expression
EXP
Vanadium results in decreased expression of ADAMTS4 mRNA
CTD
PMID:19000753
NCBI chr 1:161,184,302...161,199,054
Ensembl chr 1:161,184,302...161,199,054
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
NL-71-101 inhibits the reaction [Vanadium results in increased expression of ADIPOQ protein]; Vanadium results in increased expression of and results in increased secretion of ADIPOQ protein
CTD
PMID:16524741
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
AHR
aryl hydrocarbon receptor
multiple interactions
EXP ISO
Vanadium inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 promoter] Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]
CTD
PMID:18541696 PMID:23423713
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
AKT1
AKT serine/threonine kinase 1
multiple interactions
ISO
PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein]; PRKCI protein mutant form inhibits the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein]; Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein
CTD
PMID:14971662
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALK
ALK receptor tyrosine kinase
decreases expression
EXP
Vanadium results in decreased expression of ALK mRNA
CTD
PMID:19000753
NCBI chr 2:29,192,774...29,921,586
Ensembl chr 2:29,192,774...29,921,586
G
AOC3
amine oxidase copper containing 3
decreases expression
EXP
Vanadium results in decreased expression of AOC3 mRNA
CTD
PMID:19000753
NCBI chr17:42,851,199...42,858,124
Ensembl chr17:42,851,184...42,858,130
G
ARNT
aryl hydrocarbon receptor nuclear translocator
multiple interactions
EXP
Vanadium inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 promoter]
CTD
PMID:18541696
NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
G
ATP1B4
ATPase Na+/K+ transporting family member beta 4
decreases expression
EXP
Vanadium results in decreased expression of ATP1B4 mRNA
CTD
PMID:19000753
NCBI chr X:120,362,089...120,383,237
Ensembl chr X:120,362,085...120,383,249
G
ATP2A3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
increases expression
EXP
Vanadium results in increased expression of ATP2A3 mRNA
CTD
PMID:19000753
NCBI chr17:3,923,873...3,964,437
Ensembl chr17:3,923,870...3,964,464
G
ATP2B1
ATPase plasma membrane Ca2+ transporting 1
increases expression
EXP
Vanadium results in increased expression of ATP2B1 mRNA
CTD
PMID:19000753
NCBI chr12:89,588,049...89,709,366
Ensembl chr12:89,588,049...89,709,366
G
ATP2B2
ATPase plasma membrane Ca2+ transporting 2
increases expression
EXP
Vanadium results in increased expression of ATP2B2 mRNA
CTD
PMID:19000753
NCBI chr 3:10,324,023...10,708,007
Ensembl chr 3:10,324,023...10,708,007
G
ATP5F1B
ATP synthase F1 subunit beta
increases expression
EXP
Vanadium results in increased expression of ATP5F1B mRNA
CTD
PMID:19000753
NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984
G
ATP5MF
ATP synthase membrane subunit f
increases expression
EXP
Vanadium results in increased expression of ATP5MF mRNA
CTD
PMID:19000753
NCBI chr 7:99,458,195...99,466,167
Ensembl chr 7:99,448,475...99,466,186
G
ATP5MG
ATP synthase membrane subunit g
increases expression
EXP
Vanadium results in increased expression of ATP5MG mRNA
CTD
PMID:19000753
NCBI chr11:118,401,606...118,409,847
Ensembl chr11:118,401,346...118,433,278
G
ATP5PO
ATP synthase peripheral stalk subunit OSCP
increases expression
EXP
Vanadium results in increased expression of ATP5PO mRNA
CTD
PMID:19000753
NCBI chr21:33,903,453...33,915,804
Ensembl chr21:33,903,453...33,915,814
G
ATP6AP1
ATPase H+ transporting accessory protein 1
decreases expression
EXP
Vanadium results in decreased expression of ATP6AP1 mRNA
CTD
PMID:19000753
NCBI chr X:154,428,677...154,436,516
Ensembl chr X:154,428,633...154,436,516
G
ATP6AP2
ATPase H+ transporting accessory protein 2
increases expression
EXP
Vanadium results in increased expression of ATP6AP2 mRNA
CTD
PMID:19000753
NCBI chr X:40,580,970...40,606,848
Ensembl chr X:40,579,372...40,606,848
G
ATP6V0B
ATPase H+ transporting V0 subunit b
decreases expression
EXP
Vanadium results in decreased expression of ATP6V0B mRNA
CTD
PMID:19000753
NCBI chr 1:43,974,960...43,978,295
Ensembl chr 1:43,974,487...43,978,295
G
ATP6V0C
ATPase H+ transporting V0 subunit c
decreases expression
EXP
Vanadium results in decreased expression of ATP6V0C mRNA
CTD
PMID:19000753
NCBI chr16:2,513,726...2,520,218
Ensembl chr16:2,513,952...2,520,218
G
ATP6V1A
ATPase H+ transporting V1 subunit A
increases expression
EXP
Vanadium results in increased expression of ATP6V1A mRNA
CTD
PMID:19000753
NCBI chr 3:113,747,035...113,812,056
Ensembl chr 3:113,746,770...113,812,056
G
BMX
BMX non-receptor tyrosine kinase
decreases expression
EXP
Vanadium results in decreased expression of BMX mRNA
CTD
PMID:19000753
NCBI chr X:15,500,807...15,556,519
Ensembl chr X:15,464,246...15,556,529
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
decreases expression
EXP
Vanadium results in decreased expression of BRAF mRNA
CTD
PMID:19000753
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
G
CACNA1F
calcium voltage-gated channel subunit alpha1 F
increases expression
EXP
Vanadium results in increased expression of CACNA1F mRNA
CTD
PMID:19000753
NCBI chr X:49,205,063...49,233,340
Ensembl chr X:49,205,063...49,233,371
G
CACNA2D2
calcium voltage-gated channel auxiliary subunit alpha2delta 2
increases expression
EXP
Vanadium results in increased expression of CACNA2D2 mRNA
CTD
PMID:19000753
NCBI chr 3:50,362,613...50,504,244
Ensembl chr 3:50,362,613...50,504,244
G
CACNB1
calcium voltage-gated channel auxiliary subunit beta 1
decreases expression
EXP
Vanadium results in decreased expression of CACNB1 mRNA
CTD
PMID:19000753
NCBI chr17:39,173,453...39,197,669
Ensembl chr17:39,173,453...39,197,702
G
CACNG4
calcium voltage-gated channel auxiliary subunit gamma 4
decreases expression
EXP
Vanadium results in decreased expression of CACNG4 mRNA
CTD
PMID:19000753
NCBI chr17:66,964,707...67,033,398
Ensembl chr17:66,964,707...67,033,398
G
CAMKK2
calcium/calmodulin dependent protein kinase kinase 2
decreases expression
EXP
Vanadium results in decreased expression of CAMKK2 mRNA
CTD
PMID:19000753
NCBI chr12:121,237,692...121,297,819
Ensembl chr12:121,237,675...121,298,308
G
CCL16
C-C motif chemokine ligand 16
decreases expression
EXP
Vanadium results in decreased expression of CCL16 mRNA
CTD
PMID:19000753
NCBI chr17:35,976,499...35,981,497
Ensembl chr17:35,976,493...35,981,497
G
CCN1
cellular communication network factor 1
decreases expression
EXP
Vanadium results in decreased expression of CCN1 mRNA
CTD
PMID:19000753
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
CD36
CD36 molecule
decreases expression
EXP
Vanadium results in decreased expression of CD36 mRNA
CTD
PMID:19000753
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CDK16
cyclin dependent kinase 16
decreases expression
EXP
Vanadium results in decreased expression of CDK16 mRNA
CTD
PMID:19000753
NCBI chr X:47,218,303...47,229,997
Ensembl chr X:47,217,860...47,229,997
G
CDK17
cyclin dependent kinase 17
decreases expression
EXP
Vanadium results in decreased expression of CDK17 mRNA
CTD
PMID:19000753
NCBI chr12:96,278,225...96,400,439
Ensembl chr12:96,278,261...96,400,480
G
CDK6
cyclin dependent kinase 6
increases expression
EXP
Vanadium results in increased expression of CDK6 mRNA
CTD
PMID:19000753
NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
G
CDK8
cyclin dependent kinase 8
decreases expression
EXP
Vanadium results in decreased expression of CDK8 mRNA
CTD
PMID:19000753
NCBI chr13:26,254,129...26,405,238
Ensembl chr13:26,254,104...26,420,982
G
CEACAM8
CEA cell adhesion molecule 8
increases expression
EXP
Vanadium results in increased expression of CEACAM8 mRNA
CTD
PMID:19000753
NCBI chr19:42,580,243...42,594,924
Ensembl chr19:42,580,243...42,595,055
G
CHAT
choline O-acetyltransferase
decreases expression multiple interactions
ISO
Vanadium results in decreased expression of CHAT protein Nicotine inhibits the reaction [Vanadium results in decreased expression of CHAT protein]
CTD
PMID:22119111
NCBI chr10:49,609,095...49,667,942
Ensembl chr10:49,609,095...49,667,942
G
CLU
clusterin
increases expression
EXP
Vanadium results in increased expression of CLU mRNA
CTD
PMID:19000753
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
COL1A1
collagen type I alpha 1 chain
decreases expression
EXP
Vanadium results in decreased expression of COL1A1 mRNA
CTD
PMID:19000753
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL4A6
collagen type IV alpha 6 chain
decreases expression
EXP
Vanadium results in decreased expression of COL4A6 mRNA
CTD
PMID:19000753
NCBI chr X:108,155,614...108,439,458
Ensembl chr X:108,155,607...108,439,497
G
COL5A1
collagen type V alpha 1 chain
decreases expression
EXP
Vanadium results in decreased expression of COL5A1 mRNA
CTD
PMID:19000753
NCBI chr 9:134,641,803...134,844,843
Ensembl chr 9:134,641,803...134,844,843
G
CSK
C-terminal Src kinase
decreases expression
EXP
Vanadium results in decreased expression of CSK mRNA
CTD
PMID:19000753
NCBI chr15:74,782,080...74,803,197
Ensembl chr15:74,782,080...74,803,197
G
CSNK1A1
casein kinase 1 alpha 1
decreases expression
EXP
Vanadium results in decreased expression of CSNK1A1 mRNA
CTD
PMID:19000753
NCBI chr 5:149,492,982...149,551,439
Ensembl chr 5:149,492,982...149,551,471
G
CSNK2A2
casein kinase 2 alpha 2
decreases expression
EXP
Vanadium results in decreased expression of CSNK2A2 mRNA
CTD
PMID:19000753
NCBI chr16:58,157,907...58,198,106
Ensembl chr16:58,157,907...58,198,106
G
CUX1
cut like homeobox 1
increases activity
EXP
Vanadium results in increased activity of CUX1 protein
CTD
PMID:19000753
NCBI chr 7:101,816,007...102,283,958
Ensembl chr 7:101,815,904...102,283,958
G
CXCL2
C-X-C motif chemokine ligand 2
increases expression
ISO
Vanadium results in increased expression of CXCL2 mRNA
CTD
PMID:11708899
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
EXP
Vanadium results in increased expression of CXCL8 mRNA; Vanadium results in increased expression of CXCL8 protein
CTD
PMID:9344885 PMID:18464055
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
multiple interactions decreases expression
EXP ISO
Vanadium inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 promoter]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Vanadium results in decreased expression of CYP1A1 mRNA
CTD
PMID:18541696 PMID:20221682 PMID:23423713
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
multiple interactions
ISO
Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]
CTD
PMID:23423713
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
multiple interactions
ISO
Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1B1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1B1 protein]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]
CTD
PMID:23423713
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
DGKB
diacylglycerol kinase beta
increases expression
EXP
Vanadium results in increased expression of DGKB mRNA
CTD
PMID:19000753
NCBI chr 7:14,145,049...14,974,858
Ensembl chr 7:14,145,049...14,974,777
G
DGKG
diacylglycerol kinase gamma
decreases expression
EXP
Vanadium results in decreased expression of DGKG mRNA
CTD
PMID:19000753
NCBI chr 3:186,147,201...186,362,234
Ensembl chr 3:186,105,668...186,362,234
G
DGKI
diacylglycerol kinase iota
increases expression
EXP
Vanadium results in increased expression of DGKI mRNA
CTD
PMID:19000753
NCBI chr 7:137,381,037...137,846,974
Ensembl chr 7:137,381,037...137,847,092
G
DGKQ
diacylglycerol kinase theta
decreases expression
EXP
Vanadium results in decreased expression of DGKQ mRNA
CTD
PMID:19000753
NCBI chr 4:958,887...973,569
Ensembl chr 4:958,887...986,895
G
ETV4
ETS variant transcription factor 4
increases activity
EXP
Vanadium results in increased activity of ETV4 protein
CTD
PMID:19000753
NCBI chr17:43,527,846...43,546,340
Ensembl chr17:43,527,844...43,579,620
G
FGF17
fibroblast growth factor 17
decreases expression
EXP
Vanadium results in decreased expression of FGF17 mRNA
CTD
PMID:19000753
NCBI chr 8:22,039,672...22,048,809
Ensembl chr 8:22,042,398...22,048,809
G
FGFBP1
fibroblast growth factor binding protein 1
decreases expression
EXP
Vanadium results in decreased expression of FGFBP1 mRNA
CTD
PMID:19000753
NCBI chr 4:15,935,577...15,938,740
Ensembl chr 4:15,935,577...15,938,740
G
GJA1
gap junction protein alpha 1
increases expression
ISO
Vanadium results in increased expression of GJA1 mRNA
CTD
PMID:15159208
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GP1BB
glycoprotein Ib platelet subunit beta
decreases expression
EXP
Vanadium results in decreased expression of GP1BB mRNA
CTD
PMID:19000753
NCBI chr22:19,723,539...19,724,771
Ensembl chr22:19,723,539...19,724,771
G
HGF
hepatocyte growth factor
decreases expression
EXP
Vanadium results in decreased expression of HGF mRNA
CTD
PMID:19000753
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
HIF1A
hypoxia inducible factor 1 subunit alpha
multiple interactions
EXP
Vanadium results in increased expression of and results in increased activity of HIF1A protein
CTD
PMID:16386771
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
Vanadium results in increased expression of HSPA1A mRNA
CTD
PMID:15159208
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
ICAM1
intercellular adhesion molecule 1
multiple interactions
EXP
[Particulate Matter results in increased abundance of Vanadium] which results in increased expression of ICAM1 protein
CTD
PMID:26732377
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
ICAM4
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
decreases expression
EXP
Vanadium results in decreased expression of ICAM4 mRNA
CTD
PMID:19000753
NCBI chr19:10,286,955...10,288,520
Ensembl chr19:10,286,955...10,288,522
G
IFNG
interferon gamma
multiple interactions
EXP
[Air Pollutants results in increased abundance of Vanadium] which results in decreased methylation of IFNG promoter
CTD
PMID:28424066
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IGFBP4
insulin like growth factor binding protein 4
decreases expression
EXP
Vanadium results in decreased expression of IGFBP4 mRNA
CTD
PMID:19000753
NCBI chr17:40,443,450...40,457,725
Ensembl chr17:40,443,450...40,457,725
G
IGFBP5
insulin like growth factor binding protein 5
increases expression
EXP
Vanadium results in increased expression of IGFBP5 mRNA
CTD
PMID:19000753
NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
G
IL10
interleukin 10
multiple interactions
ISO
[Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in decreased expression of IL10 protein]
CTD
PMID:15862027
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL1A
interleukin 1 alpha
increases expression
ISO
Vanadium results in increased expression of IL1A mRNA
CTD
PMID:15159208
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL4
interleukin 4
multiple interactions
ISO EXP
[Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] results in increased expression of IL4 protein [Air Pollutants results in increased abundance of Vanadium] which results in decreased methylation of IL4 promoter
CTD
PMID:15862027 PMID:28424066
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6
interleukin 6
increases expression
EXP ISO
Vanadium results in increased expression of IL6 mRNA; Vanadium results in increased expression of IL6 protein
CTD
PMID:9344885 PMID:15159208
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
INS-IGF2
INS-IGF2 readthrough
multiple interactions
ISO
[Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 mRNA; [Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 protein
CTD
PMID:20108212
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
G
INSIG1
insulin induced gene 1
decreases expression
EXP
Vanadium results in decreased expression of INSIG1 mRNA
CTD
PMID:19000753
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
G
INSL4
insulin like 4
increases expression
EXP
Vanadium results in increased expression of INSL4 mRNA
CTD
PMID:19000753
NCBI chr 9:5,231,419...5,235,304
Ensembl chr 9:5,231,419...5,235,304
G
INSL5
insulin like 5
increases expression
EXP
Vanadium results in increased expression of INSL5 mRNA
CTD
PMID:19000753
NCBI chr 1:66,797,740...66,801,276
Ensembl chr 1:66,797,740...66,801,276
G
IRF1
interferon regulatory factor 1
increases activity
EXP
Vanadium results in increased activity of IRF1 protein
CTD
PMID:19000753
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
G
ITGA10
integrin subunit alpha 10
decreases expression
EXP
Vanadium results in decreased expression of ITGA10 mRNA
CTD
PMID:19000753
NCBI chr 1:145,891,208...145,910,050
Ensembl chr 1:145,891,208...145,910,111
G
ITGA3
integrin subunit alpha 3
decreases expression
EXP
Vanadium results in decreased expression of ITGA3 mRNA
CTD
PMID:19000753
NCBI chr17:50,056,110...50,090,481
Ensembl chr17:50,055,968...50,090,481
G
ITGAX
integrin subunit alpha X
decreases expression
EXP
Vanadium results in decreased expression of ITGAX mRNA
CTD
PMID:19000753
NCBI chr16:31,355,176...31,382,999
Ensembl chr16:31,355,134...31,382,999
G
ITGB7
integrin subunit beta 7
increases expression
EXP
Vanadium results in increased expression of ITGB7 mRNA
CTD
PMID:19000753
NCBI chr12:53,191,323...53,207,251
Ensembl chr12:53,191,323...53,207,282
G
JAK3
Janus kinase 3
decreases expression
EXP
Vanadium results in decreased expression of JAK3 mRNA
CTD
PMID:19000753
NCBI chr19:17,824,782...17,847,982
Ensembl chr19:17,824,780...17,848,071
G
KCNA3
potassium voltage-gated channel subfamily A member 3
decreases expression
EXP
Vanadium results in decreased expression of KCNA3 mRNA
CTD
PMID:19000753
NCBI chr 1:110,653,560...110,674,940
Ensembl chr 1:110,653,560...110,674,940
G
KCNC1
potassium voltage-gated channel subfamily C member 1
decreases expression
EXP
Vanadium results in decreased expression of KCNC1 mRNA
CTD
PMID:19000753
NCBI chr11:17,734,781...17,783,057
Ensembl chr11:17,734,774...17,856,804
G
KCNQ1
potassium voltage-gated channel subfamily Q member 1
increases expression
ISO
Vanadium results in increased expression of KCNQ1 mRNA
CTD
PMID:15159208
NCBI chr11:2,445,008...2,849,105
Ensembl chr11:2,444,654...2,849,105
G
KCNQ3
potassium voltage-gated channel subfamily Q member 3
increases expression
EXP
Vanadium results in increased expression of KCNQ3 mRNA
CTD
PMID:19000753
NCBI chr 8:132,120,861...132,481,095
Ensembl chr 8:132,120,861...132,481,095
G
KCNQ4
potassium voltage-gated channel subfamily Q member 4
decreases expression
EXP
Vanadium results in decreased expression of KCNQ4 mRNA
CTD
PMID:19000753
NCBI chr 1:40,783,787...40,840,452
Ensembl chr 1:40,783,787...40,840,452
G
KLF11
KLF transcription factor 11
decreases expression
EXP
Vanadium results in decreased expression of KLF11 mRNA
CTD
PMID:19000753
NCBI chr 2:10,043,550...10,054,836
Ensembl chr 2:10,042,849...10,054,836
G
LEP
leptin
multiple interactions
ISO
Vanadium promotes the reaction [LEP protein results in increased expression of UCP1 protein]; Vanadium promotes the reaction [LEP protein results in increased phosphorylation of STAT3 protein]
CTD
PMID:16195403
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LITAF
lipopolysaccharide induced TNF factor
multiple interactions
EXP
[Titanium co-treated with Vanadium co-treated with Aluminum] results in increased expression of LITAF mRNA
CTD
PMID:17408380
NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,547,722...11,636,381
G
MAP2K6
mitogen-activated protein kinase kinase 6
increases expression
EXP
Vanadium results in increased expression of MAP2K6 mRNA
CTD
PMID:19000753
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
G
MAP3K14
mitogen-activated protein kinase kinase kinase 14
decreases expression
EXP
Vanadium results in decreased expression of MAP3K14 mRNA
CTD
PMID:19000753
NCBI chr17:45,263,119...45,317,020
Ensembl chr17:45,263,119...45,317,029
G
MAP3K2
mitogen-activated protein kinase kinase kinase 2
increases expression
EXP
Vanadium results in increased expression of MAP3K2 mRNA
CTD
PMID:19000753
NCBI chr 2:127,298,668...127,388,465
Ensembl chr 2:127,298,668...127,388,465
G
MAP3K4
mitogen-activated protein kinase kinase kinase 4
decreases expression
EXP
Vanadium results in decreased expression of MAP3K4 mRNA
CTD
PMID:19000753
NCBI chr 6:160,991,769...161,117,380
Ensembl chr 6:160,991,727...161,117,385
G
MAP4K4
mitogen-activated protein kinase kinase kinase kinase 4
decreases expression
EXP
Vanadium results in decreased expression of MAP4K4 mRNA
CTD
PMID:19000753
NCBI chr 2:101,697,707...101,894,690
Ensembl chr 2:101,696,850...101,894,690
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions increases phosphorylation
ISO EXP
[Vanadium co-treated with Iron] results in increased phosphorylation of MAPK1 protein; Vanadium results in increased phosphorylation of and results in increased activity of MAPK1 protein Vanadium results in increased phosphorylation of MAPK1 protein
CTD
PMID:14622970 PMID:16079071 PMID:16728372
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions increases phosphorylation
ISO EXP
[Vanadium co-treated with Iron] results in increased phosphorylation of MAPK3 protein; Vanadium results in increased phosphorylation of and results in increased activity of MAPK3 protein Vanadium results in increased phosphorylation of MAPK3 protein
CTD
PMID:14622970 PMID:16079071 PMID:16728372
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPKAPK3
MAPK activated protein kinase 3
increases expression
EXP
Vanadium results in increased expression of MAPKAPK3 mRNA
CTD
PMID:19000753
NCBI chr 3:50,611,520...50,649,291
Ensembl chr 3:50,611,520...50,649,291
G
MEGF8
multiple EGF like domains 8
increases expression
EXP
Vanadium results in increased expression of MEGF8 mRNA
CTD
PMID:19000753
NCBI chr19:42,325,635...42,378,765
Ensembl chr19:42,325,609...42,378,769
G
MFAP2
microfibril associated protein 2
increases expression
EXP
Vanadium results in increased expression of MFAP2 mRNA
CTD
PMID:19000753
NCBI chr 1:16,974,502...16,981,583
Ensembl chr 1:16,974,502...16,980,632
G
MKI67
marker of proliferation Ki-67
multiple interactions
ISO
Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]
CTD
PMID:15565650
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
G
MMP1
matrix metallopeptidase 1
decreases expression
EXP
Vanadium results in decreased expression of MMP1 mRNA
CTD
PMID:19000753
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP14
matrix metallopeptidase 14
increases expression
EXP
Vanadium results in increased expression of MMP14 mRNA
CTD
PMID:19000753
NCBI chr14:22,836,585...22,847,758
Ensembl chr14:22,836,560...22,849,041
G
MST1R
macrophage stimulating 1 receptor
decreases expression
EXP
Vanadium results in decreased expression of MST1R mRNA
CTD
PMID:19000753
NCBI chr 3:49,887,002...49,903,873
Ensembl chr 3:49,887,002...49,903,873
G
MT1A
metallothionein 1A
multiple interactions
ISO
Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MT1A protein]
CTD
PMID:15565650
NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
increases expression
EXP
Vanadium results in increased expression of MUC5AC mRNA
CTD
PMID:10637131
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
MYO18A
myosin XVIIIA
decreases expression
EXP
Vanadium results in decreased expression of MYO18A mRNA
CTD
PMID:19000753
NCBI chr17:29,071,122...29,180,398
Ensembl chr17:29,071,122...29,180,398
G
NDRG1
N-myc downstream regulated 1
increases expression
EXP
Vanadium results in increased expression of NDRG1 protein
CTD
PMID:16386771
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
G
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
increases activity
EXP
Vanadium results in increased activity of NEDD9 protein
CTD
PMID:19000753
NCBI chr 6:11,183,298...11,382,348
Ensembl chr 6:11,183,298...11,382,348
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO EXP
Vanadium inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NOS2 mRNA] [Air Pollutants results in increased abundance of Vanadium] which results in decreased methylation of NOS2 promoter
CTD
PMID:18155637 PMID:28424066
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
increases expression
EXP
Vanadium results in increased expression of NOS3 mRNA
CTD
PMID:19000753
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NPY
neuropeptide Y
increases expression
EXP
Vanadium results in increased expression of NPY mRNA
CTD
PMID:19000753
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
NQO1
NAD(P)H quinone dehydrogenase 1
multiple interactions decreases expression increases stability
ISO
Vanadium inhibits the reaction [sulforaphane affects the localization of NQO1 protein]; Vanadium inhibits the reaction [sulforaphane results in increased activity of NQO1 protein]; Vanadium inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Vanadium inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NQO1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein] Vanadium results in decreased expression of NQO1 mRNA Vanadium results in increased stability of NQO1 protein
CTD
PMID:19367690
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NRCAM
neuronal cell adhesion molecule
decreases expression
EXP
Vanadium results in decreased expression of NRCAM mRNA
CTD
PMID:19000753
NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
G
P4HB
prolyl 4-hydroxylase subunit beta
decreases expression
EXP
Vanadium results in decreased expression of P4HB mRNA
CTD
PMID:19000753
NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
G
PCNA
proliferating cell nuclear antigen
multiple interactions
ISO
Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]; Vanadium inhibits the reaction [Diethylnitrosamine results in increased expression of PCNA protein]
CTD
PMID:16352317 PMID:16878318
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PECAM1
platelet and endothelial cell adhesion molecule 1
decreases expression
EXP
Vanadium results in decreased expression of PECAM1 mRNA
CTD
PMID:19000753
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PFKP
phosphofructokinase, platelet
decreases expression
EXP
Vanadium results in decreased expression of PFKP mRNA
CTD
PMID:19000753
NCBI chr10:3,067,548...3,136,805
Ensembl chr10:3,066,333...3,137,718
G
PICK1
protein interacting with PRKCA 1
decreases expression
EXP
Vanadium results in decreased expression of PICK1 mRNA
CTD
PMID:19000753
NCBI chr22:38,057,255...38,075,701
Ensembl chr22:38,056,311...38,075,701
G
PIK3R3
phosphoinositide-3-kinase regulatory subunit 3
increases expression
EXP
Vanadium results in increased expression of PIK3R3 mRNA
CTD
PMID:19000753
NCBI chr 1:46,040,140...46,174,901
Ensembl chr 1:46,040,140...46,133,036
G
PKN1
protein kinase N1
decreases expression
EXP
Vanadium results in decreased expression of PKN1 mRNA
CTD
PMID:19000753
NCBI chr19:14,433,306...14,471,859
Ensembl chr19:14,433,053...14,471,867
G
PLA2G2A
phospholipase A2 group IIA
increases expression
EXP
Vanadium results in increased expression of PLA2G2A mRNA
CTD
PMID:19000753
NCBI chr 1:19,975,431...19,980,434
Ensembl chr 1:19,975,431...19,980,416
G
PLAU
plasminogen activator, urokinase
increases expression
EXP
Vanadium results in increased expression of PLAU mRNA
CTD
PMID:19000753
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
decreases expression
EXP
Vanadium results in decreased expression of PRKACA mRNA
CTD
PMID:19000753
NCBI chr19:14,091,688...14,117,762
Ensembl chr19:14,091,688...14,118,084
G
PRKACG
protein kinase cAMP-activated catalytic subunit gamma
decreases expression
EXP
Vanadium results in decreased expression of PRKACG mRNA
CTD
PMID:19000753
NCBI chr 9:69,012,504...69,014,113
Ensembl chr 9:69,012,504...69,014,113
G
PRKCA
protein kinase C alpha
multiple interactions
ISO
PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein]; PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]
CTD
PMID:14971662
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
G
PRKCB
protein kinase C beta
decreases expression
EXP
Vanadium results in decreased expression of PRKCB mRNA
CTD
PMID:19000753
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
G
PRKCD
protein kinase C delta
increases expression
EXP
Vanadium results in increased expression of PRKCD mRNA
CTD
PMID:19000753
NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
G
PRKCI
protein kinase C iota
affects localization increases expression multiple interactions
ISO EXP
Vanadium affects the localization of PRKCI protein Vanadium results in increased expression of PRKCI mRNA PRKCI protein mutant form inhibits the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein]
CTD
PMID:14971662 PMID:19000753
NCBI chr 3:170,222,424...170,305,977
Ensembl chr 3:170,222,424...170,305,977
G
PRKCQ
protein kinase C theta
decreases expression
EXP
Vanadium results in decreased expression of PRKCQ mRNA
CTD
PMID:19000753
NCBI chr10:6,394,097...6,580,646
Ensembl chr10:6,427,143...6,580,301
G
PRKCZ
protein kinase C zeta
affects localization
ISO
Vanadium affects the localization of PRKCZ protein
CTD
PMID:14971662
NCBI chr 1:2,048,504...2,185,395
Ensembl chr 1:2,050,411...2,185,395
G
PRKD1
protein kinase D1
decreases expression
EXP
Vanadium results in decreased expression of PRKD1 mRNA
CTD
PMID:19000753
NCBI chr14:29,576,479...29,927,847
Ensembl chr14:29,576,479...30,191,898
G
PRKG1
protein kinase cGMP-dependent 1
decreases expression
EXP
Vanadium results in decreased expression of PRKG1 mRNA
CTD
PMID:19000753
NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423
G
PRKG2
protein kinase cGMP-dependent 2
decreases expression
EXP
Vanadium results in decreased expression of PRKG2 mRNA
CTD
PMID:19000753
NCBI chr 4:81,087,370...81,217,836
Ensembl chr 4:81,087,370...81,215,222
G
PTGS1
prostaglandin-endoperoxide synthase 1
multiple interactions
EXP
[Vanadates results in increased abundance of Vanadium] which results in decreased expression of PTGS1 protein
CTD
PMID:25398544
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with [Vanadates results in increased abundance of Vanadium]] results in increased expression of PTGS2 protein
CTD
PMID:25398544
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTK2B
protein tyrosine kinase 2 beta
decreases expression
EXP
Vanadium results in decreased expression of PTK2B mRNA
CTD
PMID:19000753
NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,482...27,459,391
G
PTK6
protein tyrosine kinase 6
decreases expression
EXP
Vanadium results in decreased expression of PTK6 mRNA
CTD
PMID:19000753
NCBI chr20:63,528,001...63,537,376
Ensembl chr20:63,528,001...63,537,376
G
RPS6KB1
ribosomal protein S6 kinase B1
multiple interactions
ISO
PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]; Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein
CTD
PMID:14971662
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
G
S1PR4
sphingosine-1-phosphate receptor 4
increases expression
EXP
Vanadium results in increased expression of S1PR4 mRNA
CTD
PMID:19000753
NCBI chr19:3,178,769...3,180,332
Ensembl chr19:3,172,346...3,180,332
G
SCN10A
sodium voltage-gated channel alpha subunit 10
increases expression
EXP
Vanadium results in increased expression of SCN10A mRNA
CTD
PMID:19000753
NCBI chr 3:38,696,807...38,816,217
Ensembl chr 3:38,696,802...38,816,286
G
SLC11A2
solute carrier family 11 member 2
decreases expression multiple interactions
ISO
Vanadium results in decreased expression of SLC11A2 mRNA; Vanadium results in decreased expression of SLC11A2 protein Metals inhibits the reaction [SLC11A2 protein results in increased transport of Vanadium]
CTD
PMID:15908475
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
G
SLC12A2
solute carrier family 12 member 2
increases expression
EXP
Vanadium results in increased expression of SLC12A2 mRNA
CTD
PMID:19000753
NCBI chr 5:128,083,766...128,189,677
Ensembl chr 5:128,083,766...128,189,677
G
SLC12A7
solute carrier family 12 member 7
decreases expression
EXP
Vanadium results in decreased expression of SLC12A7 mRNA
CTD
PMID:19000753
NCBI chr 5:1,050,384...1,155,899
Ensembl chr 5:1,050,384...1,112,063
G
SLC13A2
solute carrier family 13 member 2
decreases expression
EXP
Vanadium results in decreased expression of SLC13A2 mRNA
CTD
PMID:19000753
NCBI chr17:28,473,644...28,497,781
Ensembl chr17:28,473,293...28,497,781
G
SLC14A2
solute carrier family 14 member 2
increases expression
EXP
Vanadium results in increased expression of SLC14A2 mRNA
CTD
PMID:19000753
NCBI chr18:45,167,963...45,683,688
Ensembl chr18:45,212,995...45,683,688
G
SLC15A1
solute carrier family 15 member 1
decreases expression
EXP
Vanadium results in decreased expression of SLC15A1 mRNA
CTD
PMID:19000753
NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672
G
SLC16A5
solute carrier family 16 member 5
increases expression
EXP
Vanadium results in increased expression of SLC16A5 mRNA
CTD
PMID:19000753
NCBI chr17:75,087,385...75,110,149
Ensembl chr17:75,087,727...75,106,162
G
SLC17A5
solute carrier family 17 member 5
increases expression
EXP
Vanadium results in increased expression of SLC17A5 mRNA
CTD
PMID:19000753
NCBI chr 6:73,593,379...73,653,992
Ensembl chr 6:73,593,379...73,653,992
G
SLC18A3
solute carrier family 18 member A3
multiple interactions decreases expression
ISO
Nicotine inhibits the reaction [Vanadium results in decreased expression of SLC18A3 protein]
CTD
PMID:22119111
NCBI chr10:49,610,310...49,612,720
Ensembl chr10:49,610,310...49,612,720
G
SLC1A1
solute carrier family 1 member 1
decreases expression
EXP
Vanadium results in decreased expression of SLC1A1 mRNA
CTD
PMID:19000753
NCBI chr 9:4,490,468...4,587,469
Ensembl chr 9:4,490,468...4,587,469
G
SLC1A4
solute carrier family 1 member 4
decreases expression
EXP
Vanadium results in decreased expression of SLC1A4 mRNA
CTD
PMID:19000753
NCBI chr 2:64,988,479...65,023,865
Ensembl chr 2:64,988,477...65,023,865
G
SLC22A14
solute carrier family 22 member 14
increases expression
EXP
Vanadium results in increased expression of SLC22A14 mRNA
CTD
PMID:19000753
NCBI chr 3:38,278,832...38,318,575
Ensembl chr 3:38,282,294...38,318,575
G
SLC22A18AS
SLC22A18 antisense RNA
decreases expression
EXP
Vanadium results in decreased expression of SLC22A18AS mRNA
CTD
PMID:19000753
NCBI chr11:2,887,344...2,903,575
Ensembl chr11:2,887,344...2,903,813
G
SLC23A1
solute carrier family 23 member 1
increases expression
EXP
Vanadium results in increased expression of SLC23A1 mRNA
CTD
PMID:19000753
NCBI chr 5:139,367,196...139,385,676
Ensembl chr 5:139,367,196...139,384,553
G
SLC2A4
solute carrier family 2 member 4
decreases expression
EXP
Vanadium results in decreased expression of SLC2A4 mRNA
CTD
PMID:19000753
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
G
SLC30A3
solute carrier family 30 member 3
decreases expression
EXP
Vanadium results in decreased expression of SLC30A3 mRNA
CTD
PMID:19000753
NCBI chr 2:27,253,684...27,275,817
Ensembl chr 2:27,253,684...27,275,817
G
SLC30A4
solute carrier family 30 member 4
decreases expression
EXP
Vanadium results in decreased expression of SLC30A4 mRNA
CTD
PMID:19000753
NCBI chr15:45,479,606...45,522,755
Ensembl chr15:45,479,606...45,522,755
G
SLC31A1
solute carrier family 31 member 1
decreases expression
EXP
Vanadium results in decreased expression of SLC31A1 mRNA
CTD
PMID:19000753
NCBI chr 9:113,221,544...113,264,492
Ensembl chr 9:113,221,544...113,264,492
G
SLC39A1
solute carrier family 39 member 1
decreases expression
EXP
Vanadium results in decreased expression of SLC39A1 mRNA
CTD
PMID:19000753
NCBI chr 1:153,959,110...153,968,184
Ensembl chr 1:153,959,099...153,968,184
G
SLC6A9
solute carrier family 6 member 9
decreases expression
EXP
Vanadium results in decreased expression of SLC6A9 mRNA
CTD
PMID:19000753
NCBI chr 1:43,996,483...44,031,462
Ensembl chr 1:43,991,500...44,031,467
G
SLCO2B1
solute carrier organic anion transporter family member 2B1
increases expression
EXP
Vanadium results in increased expression of SLCO2B1 mRNA
CTD
PMID:19000753
NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
G
SLCO4A1
solute carrier organic anion transporter family member 4A1
decreases expression
EXP
Vanadium results in decreased expression of SLCO4A1 mRNA
CTD
PMID:19000753
NCBI chr20:62,642,503...62,690,740
Ensembl chr20:62,642,503...62,685,785
G
SMARCD1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1
decreases expression
EXP
Vanadium results in decreased expression of SMARCD1 mRNA
CTD
PMID:19000753
NCBI chr12:50,085,342...50,100,707
Ensembl chr12:50,085,200...50,100,707
G
STAT3
signal transducer and activator of transcription 3
multiple interactions
ISO
Vanadium promotes the reaction [LEP protein results in increased phosphorylation of STAT3 protein]
CTD
PMID:16195403
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,540
G
STK17A
serine/threonine kinase 17a
decreases expression
EXP
Vanadium results in decreased expression of STK17A mRNA
CTD
PMID:19000753
NCBI chr 7:43,583,108...43,627,379
Ensembl chr 7:43,582,758...43,650,713
G
STK38
serine/threonine kinase 38
increases expression
EXP
Vanadium results in increased expression of STK38 mRNA
CTD
PMID:19000753
NCBI chr 6:36,493,892...36,547,479
Ensembl chr 6:36,493,892...36,547,479
G
TAP2
transporter 2, ATP binding cassette subfamily B member
increases expression
EXP
Vanadium results in increased expression of TAP2 mRNA
CTD
PMID:19000753
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
G
TBXAS1
thromboxane A synthase 1
decreases expression
EXP
Vanadium results in decreased expression of TBXAS1 mRNA
CTD
PMID:19000753
NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325
G
TIMP1
TIMP metallopeptidase inhibitor 1
decreases expression
EXP
Vanadium results in decreased expression of TIMP1 mRNA
CTD
PMID:19000753
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TNF
tumor necrosis factor
multiple interactions
EXP ISO
[Titanium co-treated with Vanadium co-treated with Aluminum] results in increased expression of TNF mRNA [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in increased expression of TNF protein]
CTD
PMID:15862027 PMID:17408380
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TP53
tumor protein p53
multiple interactions increases activity
ISO EXP
Vanadium inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TP53 protein]; Vanadium promotes the reaction [2-Acetylaminofluorene results in increased expression of TP53 protein] Vanadium results in increased activity of TP53 protein
CTD
PMID:15565650 PMID:18155637 PMID:19000753
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TROAP
trophinin associated protein
increases expression
EXP
Vanadium results in increased expression of TROAP mRNA
CTD
PMID:19000753
NCBI chr12:49,323,255...49,331,731
Ensembl chr12:49,323,236...49,331,731
G
UCP1
uncoupling protein 1
multiple interactions
ISO
Vanadium promotes the reaction [LEP protein results in increased expression of UCP1 protein]
CTD
PMID:16195403
NCBI chr 4:140,559,431...140,568,961
Ensembl chr 4:140,559,431...140,568,961
G
USF1
upstream transcription factor 1
increases activity
EXP
Vanadium results in increased activity of USF1 protein
CTD
PMID:19000753
NCBI chr 1:161,039,251...161,045,977
Ensembl chr 1:161,039,251...161,045,977
G
VCAM1
vascular cell adhesion molecule 1
multiple interactions
EXP
[Particulate Matter results in increased abundance of Vanadium] which results in increased expression of VCAM1 protein
CTD
PMID:26732377
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
G
VDAC2
voltage dependent anion channel 2
increases expression
EXP
Vanadium results in increased expression of VDAC2 mRNA
CTD
PMID:19000753
NCBI chr10:75,210,170...75,231,448
Ensembl chr10:75,210,154...75,231,448
G
VEGFD
vascular endothelial growth factor D
increases expression
EXP
Vanadium results in increased expression of VEGFD mRNA
CTD
PMID:19000753
NCBI chr X:15,345,596...15,384,413
Ensembl chr X:15,345,596...15,384,413
G
ZAP70
zeta chain of T cell receptor associated protein kinase 70
decreases expression
EXP
Vanadium results in decreased expression of ZAP70 mRNA
CTD
PMID:19000753
NCBI chr 2:97,713,576...97,756,364
Ensembl chr 2:97,713,576...97,739,862
G
CDC25C
cell division cycle 25C
increases expression
EXP
vanadium dioxide results in increased expression of CDC25C protein
CTD
PMID:33913241
NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355
G
SLC11A2
solute carrier family 11 member 2
increases transport
EXP
SLC11A2 protein results in increased transport of vanadium dioxide
CTD
PMID:22736759
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
G
TP53
tumor protein p53
increases expression
EXP
vanadium dioxide results in increased expression of TP53 protein
CTD
PMID:33913241
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
increases expression
EXP
Vanadium results in increased expression of ABL1 mRNA
CTD
PMID:19000753
NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,043...130,887,675
G
ACO1
aconitase 1
increases activity
EXP
Vanadium results in increased activity of ACO1 protein
CTD
PMID:16386771
NCBI chr 9:32,384,643...32,454,769
Ensembl chr 9:32,384,603...32,454,769
G
ADAM17
ADAM metallopeptidase domain 17
increases expression
EXP
Vanadium results in increased expression of ADAM17 mRNA
CTD
PMID:19000753
NCBI chr 2:9,488,486...9,555,830
Ensembl chr 2:9,488,486...9,556,732
G
ADAMTS4
ADAM metallopeptidase with thrombospondin type 1 motif 4
decreases expression
EXP
Vanadium results in decreased expression of ADAMTS4 mRNA
CTD
PMID:19000753
NCBI chr 1:161,184,302...161,199,054
Ensembl chr 1:161,184,302...161,199,054
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
NL-71-101 inhibits the reaction [Vanadium results in increased expression of ADIPOQ protein]; Vanadium results in increased expression of and results in increased secretion of ADIPOQ protein
CTD
PMID:16524741
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
AHR
aryl hydrocarbon receptor
multiple interactions
EXP ISO
Vanadium inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 promoter] Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]
CTD
PMID:18541696 PMID:23423713
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
AKT1
AKT serine/threonine kinase 1
multiple interactions
ISO
PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein]; PRKCI protein mutant form inhibits the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein]; Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein
CTD
PMID:14971662
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALK
ALK receptor tyrosine kinase
decreases expression
EXP
Vanadium results in decreased expression of ALK mRNA
CTD
PMID:19000753
NCBI chr 2:29,192,774...29,921,586
Ensembl chr 2:29,192,774...29,921,586
G
AOC3
amine oxidase copper containing 3
decreases expression
EXP
Vanadium results in decreased expression of AOC3 mRNA
CTD
PMID:19000753
NCBI chr17:42,851,199...42,858,124
Ensembl chr17:42,851,184...42,858,130
G
ARNT
aryl hydrocarbon receptor nuclear translocator
multiple interactions
EXP
Vanadium inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 promoter]
CTD
PMID:18541696
NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
G
ATP1B4
ATPase Na+/K+ transporting family member beta 4
decreases expression
EXP
Vanadium results in decreased expression of ATP1B4 mRNA
CTD
PMID:19000753
NCBI chr X:120,362,089...120,383,237
Ensembl chr X:120,362,085...120,383,249
G
ATP2A3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
increases expression
EXP
Vanadium results in increased expression of ATP2A3 mRNA
CTD
PMID:19000753
NCBI chr17:3,923,873...3,964,437
Ensembl chr17:3,923,870...3,964,464
G
ATP2B1
ATPase plasma membrane Ca2+ transporting 1
increases expression
EXP
Vanadium results in increased expression of ATP2B1 mRNA
CTD
PMID:19000753
NCBI chr12:89,588,049...89,709,366
Ensembl chr12:89,588,049...89,709,366
G
ATP2B2
ATPase plasma membrane Ca2+ transporting 2
increases expression
EXP
Vanadium results in increased expression of ATP2B2 mRNA
CTD
PMID:19000753
NCBI chr 3:10,324,023...10,708,007
Ensembl chr 3:10,324,023...10,708,007
G
ATP5F1B
ATP synthase F1 subunit beta
increases expression
EXP
Vanadium results in increased expression of ATP5F1B mRNA
CTD
PMID:19000753
NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984
G
ATP5MF
ATP synthase membrane subunit f
increases expression
EXP
Vanadium results in increased expression of ATP5MF mRNA
CTD
PMID:19000753
NCBI chr 7:99,458,195...99,466,167
Ensembl chr 7:99,448,475...99,466,186
G
ATP5MG
ATP synthase membrane subunit g
increases expression
EXP
Vanadium results in increased expression of ATP5MG mRNA
CTD
PMID:19000753
NCBI chr11:118,401,606...118,409,847
Ensembl chr11:118,401,346...118,433,278
G
ATP5PO
ATP synthase peripheral stalk subunit OSCP
increases expression
EXP
Vanadium results in increased expression of ATP5PO mRNA
CTD
PMID:19000753
NCBI chr21:33,903,453...33,915,804
Ensembl chr21:33,903,453...33,915,814
G
ATP6AP1
ATPase H+ transporting accessory protein 1
decreases expression
EXP
Vanadium results in decreased expression of ATP6AP1 mRNA
CTD
PMID:19000753
NCBI chr X:154,428,677...154,436,516
Ensembl chr X:154,428,633...154,436,516
G
ATP6AP2
ATPase H+ transporting accessory protein 2
increases expression
EXP
Vanadium results in increased expression of ATP6AP2 mRNA
CTD
PMID:19000753
NCBI chr X:40,580,970...40,606,848
Ensembl chr X:40,579,372...40,606,848
G
ATP6V0B
ATPase H+ transporting V0 subunit b
decreases expression
EXP
Vanadium results in decreased expression of ATP6V0B mRNA
CTD
PMID:19000753
NCBI chr 1:43,974,960...43,978,295
Ensembl chr 1:43,974,487...43,978,295
G
ATP6V0C
ATPase H+ transporting V0 subunit c
decreases expression
EXP
Vanadium results in decreased expression of ATP6V0C mRNA
CTD
PMID:19000753
NCBI chr16:2,513,726...2,520,218
Ensembl chr16:2,513,952...2,520,218
G
ATP6V1A
ATPase H+ transporting V1 subunit A
increases expression
EXP
Vanadium results in increased expression of ATP6V1A mRNA
CTD
PMID:19000753
NCBI chr 3:113,747,035...113,812,056
Ensembl chr 3:113,746,770...113,812,056
G
BMX
BMX non-receptor tyrosine kinase
decreases expression
EXP
Vanadium results in decreased expression of BMX mRNA
CTD
PMID:19000753
NCBI chr X:15,500,807...15,556,519
Ensembl chr X:15,464,246...15,556,529
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
decreases expression
EXP
Vanadium results in decreased expression of BRAF mRNA
CTD
PMID:19000753
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
G
CACNA1F
calcium voltage-gated channel subunit alpha1 F
increases expression
EXP
Vanadium results in increased expression of CACNA1F mRNA
CTD
PMID:19000753
NCBI chr X:49,205,063...49,233,340
Ensembl chr X:49,205,063...49,233,371
G
CACNA2D2
calcium voltage-gated channel auxiliary subunit alpha2delta 2
increases expression
EXP
Vanadium results in increased expression of CACNA2D2 mRNA
CTD
PMID:19000753
NCBI chr 3:50,362,613...50,504,244
Ensembl chr 3:50,362,613...50,504,244
G
CACNB1
calcium voltage-gated channel auxiliary subunit beta 1
decreases expression
EXP
Vanadium results in decreased expression of CACNB1 mRNA
CTD
PMID:19000753
NCBI chr17:39,173,453...39,197,669
Ensembl chr17:39,173,453...39,197,702
G
CACNG4
calcium voltage-gated channel auxiliary subunit gamma 4
decreases expression
EXP
Vanadium results in decreased expression of CACNG4 mRNA
CTD
PMID:19000753
NCBI chr17:66,964,707...67,033,398
Ensembl chr17:66,964,707...67,033,398
G
CAMKK2
calcium/calmodulin dependent protein kinase kinase 2
decreases expression
EXP
Vanadium results in decreased expression of CAMKK2 mRNA
CTD
PMID:19000753
NCBI chr12:121,237,692...121,297,819
Ensembl chr12:121,237,675...121,298,308
G
CCL16
C-C motif chemokine ligand 16
decreases expression
EXP
Vanadium results in decreased expression of CCL16 mRNA
CTD
PMID:19000753
NCBI chr17:35,976,499...35,981,497
Ensembl chr17:35,976,493...35,981,497
G
CCN1
cellular communication network factor 1
decreases expression
EXP
Vanadium results in decreased expression of CCN1 mRNA
CTD
PMID:19000753
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
CD36
CD36 molecule
decreases expression
EXP
Vanadium results in decreased expression of CD36 mRNA
CTD
PMID:19000753
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CDK16
cyclin dependent kinase 16
decreases expression
EXP
Vanadium results in decreased expression of CDK16 mRNA
CTD
PMID:19000753
NCBI chr X:47,218,303...47,229,997
Ensembl chr X:47,217,860...47,229,997
G
CDK17
cyclin dependent kinase 17
decreases expression
EXP
Vanadium results in decreased expression of CDK17 mRNA
CTD
PMID:19000753
NCBI chr12:96,278,225...96,400,439
Ensembl chr12:96,278,261...96,400,480
G
CDK6
cyclin dependent kinase 6
increases expression
EXP
Vanadium results in increased expression of CDK6 mRNA
CTD
PMID:19000753
NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
G
CDK8
cyclin dependent kinase 8
decreases expression
EXP
Vanadium results in decreased expression of CDK8 mRNA
CTD
PMID:19000753
NCBI chr13:26,254,129...26,405,238
Ensembl chr13:26,254,104...26,420,982
G
CEACAM8
CEA cell adhesion molecule 8
increases expression
EXP
Vanadium results in increased expression of CEACAM8 mRNA
CTD
PMID:19000753
NCBI chr19:42,580,243...42,594,924
Ensembl chr19:42,580,243...42,595,055
G
CHAT
choline O-acetyltransferase
decreases expression multiple interactions
ISO
Vanadium results in decreased expression of CHAT protein Nicotine inhibits the reaction [Vanadium results in decreased expression of CHAT protein]
CTD
PMID:22119111
NCBI chr10:49,609,095...49,667,942
Ensembl chr10:49,609,095...49,667,942
G
CLU
clusterin
increases expression
EXP
Vanadium results in increased expression of CLU mRNA
CTD
PMID:19000753
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
COL1A1
collagen type I alpha 1 chain
decreases expression
EXP
Vanadium results in decreased expression of COL1A1 mRNA
CTD
PMID:19000753
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL4A6
collagen type IV alpha 6 chain
decreases expression
EXP
Vanadium results in decreased expression of COL4A6 mRNA
CTD
PMID:19000753
NCBI chr X:108,155,614...108,439,458
Ensembl chr X:108,155,607...108,439,497
G
COL5A1
collagen type V alpha 1 chain
decreases expression
EXP
Vanadium results in decreased expression of COL5A1 mRNA
CTD
PMID:19000753
NCBI chr 9:134,641,803...134,844,843
Ensembl chr 9:134,641,803...134,844,843
G
CSK
C-terminal Src kinase
decreases expression
EXP
Vanadium results in decreased expression of CSK mRNA
CTD
PMID:19000753
NCBI chr15:74,782,080...74,803,197
Ensembl chr15:74,782,080...74,803,197
G
CSNK1A1
casein kinase 1 alpha 1
decreases expression
EXP
Vanadium results in decreased expression of CSNK1A1 mRNA
CTD
PMID:19000753
NCBI chr 5:149,492,982...149,551,439
Ensembl chr 5:149,492,982...149,551,471
G
CSNK2A2
casein kinase 2 alpha 2
decreases expression
EXP
Vanadium results in decreased expression of CSNK2A2 mRNA
CTD
PMID:19000753
NCBI chr16:58,157,907...58,198,106
Ensembl chr16:58,157,907...58,198,106
G
CUX1
cut like homeobox 1
increases activity
EXP
Vanadium results in increased activity of CUX1 protein
CTD
PMID:19000753
NCBI chr 7:101,816,007...102,283,958
Ensembl chr 7:101,815,904...102,283,958
G
CXCL2
C-X-C motif chemokine ligand 2
increases expression
ISO
Vanadium results in increased expression of CXCL2 mRNA
CTD
PMID:11708899
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
EXP
Vanadium results in increased expression of CXCL8 mRNA; Vanadium results in increased expression of CXCL8 protein
CTD
PMID:9344885 PMID:18464055
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
multiple interactions decreases expression
EXP ISO
Vanadium inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 promoter]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Vanadium results in decreased expression of CYP1A1 mRNA
CTD
PMID:18541696 PMID:20221682 PMID:23423713
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
multiple interactions
ISO
Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]
CTD
PMID:23423713
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
multiple interactions
ISO
Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1B1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1B1 protein]; Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]
CTD
PMID:23423713
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
DGKB
diacylglycerol kinase beta
increases expression
EXP
Vanadium results in increased expression of DGKB mRNA
CTD
PMID:19000753
NCBI chr 7:14,145,049...14,974,858
Ensembl chr 7:14,145,049...14,974,777
G
DGKG
diacylglycerol kinase gamma
decreases expression
EXP
Vanadium results in decreased expression of DGKG mRNA
CTD
PMID:19000753
NCBI chr 3:186,147,201...186,362,234
Ensembl chr 3:186,105,668...186,362,234
G
DGKI
diacylglycerol kinase iota
increases expression
EXP
Vanadium results in increased expression of DGKI mRNA
CTD
PMID:19000753
NCBI chr 7:137,381,037...137,846,974
Ensembl chr 7:137,381,037...137,847,092
G
DGKQ
diacylglycerol kinase theta
decreases expression
EXP
Vanadium results in decreased expression of DGKQ mRNA
CTD
PMID:19000753
NCBI chr 4:958,887...973,569
Ensembl chr 4:958,887...986,895
G
ETV4
ETS variant transcription factor 4
increases activity
EXP
Vanadium results in increased activity of ETV4 protein
CTD
PMID:19000753
NCBI chr17:43,527,846...43,546,340
Ensembl chr17:43,527,844...43,579,620
G
FGF17
fibroblast growth factor 17
decreases expression
EXP
Vanadium results in decreased expression of FGF17 mRNA
CTD
PMID:19000753
NCBI chr 8:22,039,672...22,048,809
Ensembl chr 8:22,042,398...22,048,809
G
FGFBP1
fibroblast growth factor binding protein 1
decreases expression
EXP
Vanadium results in decreased expression of FGFBP1 mRNA
CTD
PMID:19000753
NCBI chr 4:15,935,577...15,938,740
Ensembl chr 4:15,935,577...15,938,740
G
GJA1
gap junction protein alpha 1
increases expression
ISO
Vanadium results in increased expression of GJA1 mRNA
CTD
PMID:15159208
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GP1BB
glycoprotein Ib platelet subunit beta
decreases expression
EXP
Vanadium results in decreased expression of GP1BB mRNA
CTD
PMID:19000753
NCBI chr22:19,723,539...19,724,771
Ensembl chr22:19,723,539...19,724,771
G
HGF
hepatocyte growth factor
decreases expression
EXP
Vanadium results in decreased expression of HGF mRNA
CTD
PMID:19000753
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
HIF1A
hypoxia inducible factor 1 subunit alpha
multiple interactions
EXP
Vanadium results in increased expression of and results in increased activity of HIF1A protein
CTD
PMID:16386771
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
Vanadium results in increased expression of HSPA1A mRNA
CTD
PMID:15159208
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
ICAM1
intercellular adhesion molecule 1
multiple interactions
EXP
[Particulate Matter results in increased abundance of Vanadium] which results in increased expression of ICAM1 protein
CTD
PMID:26732377
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
ICAM4
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
decreases expression
EXP
Vanadium results in decreased expression of ICAM4 mRNA
CTD
PMID:19000753
NCBI chr19:10,286,955...10,288,520
Ensembl chr19:10,286,955...10,288,522
G
IFNG
interferon gamma
multiple interactions
EXP
[Air Pollutants results in increased abundance of Vanadium] which results in decreased methylation of IFNG promoter
CTD
PMID:28424066
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IGFBP4
insulin like growth factor binding protein 4
decreases expression
EXP
Vanadium results in decreased expression of IGFBP4 mRNA
CTD
PMID:19000753
NCBI chr17:40,443,450...40,457,725
Ensembl chr17:40,443,450...40,457,725
G
IGFBP5
insulin like growth factor binding protein 5
increases expression
EXP
Vanadium results in increased expression of IGFBP5 mRNA
CTD
PMID:19000753
NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
G
IL10
interleukin 10
multiple interactions
ISO
[Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in decreased expression of IL10 protein]
CTD
PMID:15862027
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL1A
interleukin 1 alpha
increases expression
ISO
Vanadium results in increased expression of IL1A mRNA
CTD
PMID:15159208
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL4
interleukin 4
multiple interactions
ISO EXP
[Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] results in increased expression of IL4 protein [Air Pollutants results in increased abundance of Vanadium] which results in decreased methylation of IL4 promoter
CTD
PMID:15862027 PMID:28424066
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6
interleukin 6
increases expression
EXP ISO
Vanadium results in increased expression of IL6 mRNA; Vanadium results in increased expression of IL6 protein
CTD
PMID:9344885 PMID:15159208
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
INS-IGF2
INS-IGF2 readthrough
multiple interactions
ISO
[Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 mRNA; [Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 protein
CTD
PMID:20108212
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
G
INSIG1
insulin induced gene 1
decreases expression
EXP
Vanadium results in decreased expression of INSIG1 mRNA
CTD
PMID:19000753
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
G
INSL4
insulin like 4
increases expression
EXP
Vanadium results in increased expression of INSL4 mRNA
CTD
PMID:19000753
NCBI chr 9:5,231,419...5,235,304
Ensembl chr 9:5,231,419...5,235,304
G
INSL5
insulin like 5
increases expression
EXP
Vanadium results in increased expression of INSL5 mRNA
CTD
PMID:19000753
NCBI chr 1:66,797,740...66,801,276
Ensembl chr 1:66,797,740...66,801,276
G
IRF1
interferon regulatory factor 1
increases activity
EXP
Vanadium results in increased activity of IRF1 protein
CTD
PMID:19000753
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
G
ITGA10
integrin subunit alpha 10
decreases expression
EXP
Vanadium results in decreased expression of ITGA10 mRNA
CTD
PMID:19000753
NCBI chr 1:145,891,208...145,910,050
Ensembl chr 1:145,891,208...145,910,111
G
ITGA3
integrin subunit alpha 3
decreases expression
EXP
Vanadium results in decreased expression of ITGA3 mRNA
CTD
PMID:19000753
NCBI chr17:50,056,110...50,090,481
Ensembl chr17:50,055,968...50,090,481
G
ITGAX
integrin subunit alpha X
decreases expression
EXP
Vanadium results in decreased expression of ITGAX mRNA
CTD
PMID:19000753
NCBI chr16:31,355,176...31,382,999
Ensembl chr16:31,355,134...31,382,999
G
ITGB7
integrin subunit beta 7
increases expression
EXP
Vanadium results in increased expression of ITGB7 mRNA
CTD
PMID:19000753
NCBI chr12:53,191,323...53,207,251
Ensembl chr12:53,191,323...53,207,282
G
JAK3
Janus kinase 3
decreases expression
EXP
Vanadium results in decreased expression of JAK3 mRNA
CTD
PMID:19000753
NCBI chr19:17,824,782...17,847,982
Ensembl chr19:17,824,780...17,848,071
G
KCNA3
potassium voltage-gated channel subfamily A member 3
decreases expression
EXP
Vanadium results in decreased expression of KCNA3 mRNA
CTD
PMID:19000753
NCBI chr 1:110,653,560...110,674,940
Ensembl chr 1:110,653,560...110,674,940
G
KCNC1
potassium voltage-gated channel subfamily C member 1
decreases expression
EXP
Vanadium results in decreased expression of KCNC1 mRNA
CTD
PMID:19000753
NCBI chr11:17,734,781...17,783,057
Ensembl chr11:17,734,774...17,856,804
G
KCNQ1
potassium voltage-gated channel subfamily Q member 1
increases expression
ISO
Vanadium results in increased expression of KCNQ1 mRNA
CTD
PMID:15159208
NCBI chr11:2,445,008...2,849,105
Ensembl chr11:2,444,654...2,849,105
G
KCNQ3
potassium voltage-gated channel subfamily Q member 3
increases expression
EXP
Vanadium results in increased expression of KCNQ3 mRNA
CTD
PMID:19000753
NCBI chr 8:132,120,861...132,481,095
Ensembl chr 8:132,120,861...132,481,095
G
KCNQ4
potassium voltage-gated channel subfamily Q member 4
decreases expression
EXP
Vanadium results in decreased expression of KCNQ4 mRNA
CTD
PMID:19000753
NCBI chr 1:40,783,787...40,840,452
Ensembl chr 1:40,783,787...40,840,452
G
KLF11
KLF transcription factor 11
decreases expression
EXP
Vanadium results in decreased expression of KLF11 mRNA
CTD
PMID:19000753
NCBI chr 2:10,043,550...10,054,836
Ensembl chr 2:10,042,849...10,054,836
G
LEP
leptin
multiple interactions
ISO
Vanadium promotes the reaction [LEP protein results in increased expression of UCP1 protein]; Vanadium promotes the reaction [LEP protein results in increased phosphorylation of STAT3 protein]
CTD
PMID:16195403
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LITAF
lipopolysaccharide induced TNF factor
multiple interactions
EXP
[Titanium co-treated with Vanadium co-treated with Aluminum] results in increased expression of LITAF mRNA
CTD
PMID:17408380
NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,547,722...11,636,381
G
MAP2K6
mitogen-activated protein kinase kinase 6
increases expression
EXP
Vanadium results in increased expression of MAP2K6 mRNA
CTD
PMID:19000753
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
G
MAP3K14
mitogen-activated protein kinase kinase kinase 14
decreases expression
EXP
Vanadium results in decreased expression of MAP3K14 mRNA
CTD
PMID:19000753
NCBI chr17:45,263,119...45,317,020
Ensembl chr17:45,263,119...45,317,029
G
MAP3K2
mitogen-activated protein kinase kinase kinase 2
increases expression
EXP
Vanadium results in increased expression of MAP3K2 mRNA
CTD
PMID:19000753
NCBI chr 2:127,298,668...127,388,465
Ensembl chr 2:127,298,668...127,388,465
G
MAP3K4
mitogen-activated protein kinase kinase kinase 4
decreases expression
EXP
Vanadium results in decreased expression of MAP3K4 mRNA
CTD
PMID:19000753
NCBI chr 6:160,991,769...161,117,380
Ensembl chr 6:160,991,727...161,117,385
G
MAP4K4
mitogen-activated protein kinase kinase kinase kinase 4
decreases expression
EXP
Vanadium results in decreased expression of MAP4K4 mRNA
CTD
PMID:19000753
NCBI chr 2:101,697,707...101,894,690
Ensembl chr 2:101,696,850...101,894,690
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions increases phosphorylation
ISO EXP
[Vanadium co-treated with Iron] results in increased phosphorylation of MAPK1 protein; Vanadium results in increased phosphorylation of and results in increased activity of MAPK1 protein Vanadium results in increased phosphorylation of MAPK1 protein
CTD
PMID:14622970 PMID:16079071 PMID:16728372
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions increases phosphorylation
ISO EXP
[Vanadium co-treated with Iron] results in increased phosphorylation of MAPK3 protein; Vanadium results in increased phosphorylation of and results in increased activity of MAPK3 protein Vanadium results in increased phosphorylation of MAPK3 protein
CTD
PMID:14622970 PMID:16079071 PMID:16728372
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPKAPK3
MAPK activated protein kinase 3
increases expression
EXP
Vanadium results in increased expression of MAPKAPK3 mRNA
CTD
PMID:19000753
NCBI chr 3:50,611,520...50,649,291
Ensembl chr 3:50,611,520...50,649,291
G
MEGF8
multiple EGF like domains 8
increases expression
EXP
Vanadium results in increased expression of MEGF8 mRNA
CTD
PMID:19000753
NCBI chr19:42,325,635...42,378,765
Ensembl chr19:42,325,609...42,378,769
G
MFAP2
microfibril associated protein 2
increases expression
EXP
Vanadium results in increased expression of MFAP2 mRNA
CTD
PMID:19000753
NCBI chr 1:16,974,502...16,981,583
Ensembl chr 1:16,974,502...16,980,632
G
MKI67
marker of proliferation Ki-67
multiple interactions
ISO
Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]
CTD
PMID:15565650
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
G
MMP1
matrix metallopeptidase 1
decreases expression
EXP
Vanadium results in decreased expression of MMP1 mRNA
CTD
PMID:19000753
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP14
matrix metallopeptidase 14
increases expression
EXP
Vanadium results in increased expression of MMP14 mRNA
CTD
PMID:19000753
NCBI chr14:22,836,585...22,847,758
Ensembl chr14:22,836,560...22,849,041
G
MST1R
macrophage stimulating 1 receptor
decreases expression
EXP
Vanadium results in decreased expression of MST1R mRNA
CTD
PMID:19000753
NCBI chr 3:49,887,002...49,903,873
Ensembl chr 3:49,887,002...49,903,873
G
MT1A
metallothionein 1A
multiple interactions
ISO
Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MT1A protein]
CTD
PMID:15565650
NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
increases expression
EXP
Vanadium results in increased expression of MUC5AC mRNA
CTD
PMID:10637131
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
MYO18A
myosin XVIIIA
decreases expression
EXP
Vanadium results in decreased expression of MYO18A mRNA
CTD
PMID:19000753
NCBI chr17:29,071,122...29,180,398
Ensembl chr17:29,071,122...29,180,398
G
NDRG1
N-myc downstream regulated 1
increases expression
EXP
Vanadium results in increased expression of NDRG1 protein
CTD
PMID:16386771
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
G
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
increases activity
EXP
Vanadium results in increased activity of NEDD9 protein
CTD
PMID:19000753
NCBI chr 6:11,183,298...11,382,348
Ensembl chr 6:11,183,298...11,382,348
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO EXP
Vanadium inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NOS2 mRNA] [Air Pollutants results in increased abundance of Vanadium] which results in decreased methylation of NOS2 promoter
CTD
PMID:18155637 PMID:28424066
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
increases expression
EXP
Vanadium results in increased expression of NOS3 mRNA
CTD
PMID:19000753
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NPY
neuropeptide Y
increases expression
EXP
Vanadium results in increased expression of NPY mRNA
CTD
PMID:19000753
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
NQO1
NAD(P)H quinone dehydrogenase 1
multiple interactions decreases expression increases stability
ISO
Vanadium inhibits the reaction [sulforaphane affects the localization of NQO1 protein]; Vanadium inhibits the reaction [sulforaphane results in increased activity of NQO1 protein]; Vanadium inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Vanadium inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NQO1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein] Vanadium results in decreased expression of NQO1 mRNA Vanadium results in increased stability of NQO1 protein
CTD
PMID:19367690
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NRCAM
neuronal cell adhesion molecule
decreases expression
EXP
Vanadium results in decreased expression of NRCAM mRNA
CTD
PMID:19000753
NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
G
P4HB
prolyl 4-hydroxylase subunit beta
decreases expression
EXP
Vanadium results in decreased expression of P4HB mRNA
CTD
PMID:19000753
NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
G
PCNA
proliferating cell nuclear antigen
multiple interactions
ISO
Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]; Vanadium inhibits the reaction [Diethylnitrosamine results in increased expression of PCNA protein]
CTD
PMID:16352317 PMID:16878318
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PECAM1
platelet and endothelial cell adhesion molecule 1
decreases expression
EXP
Vanadium results in decreased expression of PECAM1 mRNA
CTD
PMID:19000753
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PFKP
phosphofructokinase, platelet
decreases expression
EXP
Vanadium results in decreased expression of PFKP mRNA
CTD
PMID:19000753
NCBI chr10:3,067,548...3,136,805
Ensembl chr10:3,066,333...3,137,718
G
PICK1
protein interacting with PRKCA 1
decreases expression
EXP
Vanadium results in decreased expression of PICK1 mRNA
CTD
PMID:19000753
NCBI chr22:38,057,255...38,075,701
Ensembl chr22:38,056,311...38,075,701
G
PIK3R3
phosphoinositide-3-kinase regulatory subunit 3
increases expression
EXP
Vanadium results in increased expression of PIK3R3 mRNA
CTD
PMID:19000753
NCBI chr 1:46,040,140...46,174,901
Ensembl chr 1:46,040,140...46,133,036
G
PKN1
protein kinase N1
decreases expression
EXP
Vanadium results in decreased expression of PKN1 mRNA
CTD
PMID:19000753
NCBI chr19:14,433,306...14,471,859
Ensembl chr19:14,433,053...14,471,867
G
PLA2G2A
phospholipase A2 group IIA
increases expression
EXP
Vanadium results in increased expression of PLA2G2A mRNA
CTD
PMID:19000753
NCBI chr 1:19,975,431...19,980,434
Ensembl chr 1:19,975,431...19,980,416
G
PLAU
plasminogen activator, urokinase
increases expression
EXP
Vanadium results in increased expression of PLAU mRNA
CTD
PMID:19000753
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
decreases expression
EXP
Vanadium results in decreased expression of PRKACA mRNA
CTD
PMID:19000753
NCBI chr19:14,091,688...14,117,762
Ensembl chr19:14,091,688...14,118,084
G
PRKACG
protein kinase cAMP-activated catalytic subunit gamma
decreases expression
EXP
Vanadium results in decreased expression of PRKACG mRNA
CTD
PMID:19000753
NCBI chr 9:69,012,504...69,014,113
Ensembl chr 9:69,012,504...69,014,113
G
PRKCA
protein kinase C alpha
multiple interactions
ISO
PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein]; PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]
CTD
PMID:14971662
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
G
PRKCB
protein kinase C beta
decreases expression
EXP
Vanadium results in decreased expression of PRKCB mRNA
CTD
PMID:19000753
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
G
PRKCD
protein kinase C delta
increases expression
EXP
Vanadium results in increased expression of PRKCD mRNA
CTD
PMID:19000753
NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
G
PRKCI
protein kinase C iota
affects localization increases expression multiple interactions
ISO EXP
Vanadium affects the localization of PRKCI protein Vanadium results in increased expression of PRKCI mRNA PRKCI protein mutant form inhibits the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein]
CTD
PMID:14971662 PMID:19000753
NCBI chr 3:170,222,424...170,305,977
Ensembl chr 3:170,222,424...170,305,977
G
PRKCQ
protein kinase C theta
decreases expression
EXP
Vanadium results in decreased expression of PRKCQ mRNA
CTD
PMID:19000753
NCBI chr10:6,394,097...6,580,646
Ensembl chr10:6,427,143...6,580,301
G
PRKCZ
protein kinase C zeta
affects localization
ISO
Vanadium affects the localization of PRKCZ protein
CTD
PMID:14971662
NCBI chr 1:2,048,504...2,185,395
Ensembl chr 1:2,050,411...2,185,395
G
PRKD1
protein kinase D1
decreases expression
EXP
Vanadium results in decreased expression of PRKD1 mRNA
CTD
PMID:19000753
NCBI chr14:29,576,479...29,927,847
Ensembl chr14:29,576,479...30,191,898
G
PRKG1
protein kinase cGMP-dependent 1
decreases expression
EXP
Vanadium results in decreased expression of PRKG1 mRNA
CTD
PMID:19000753
NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423
G
PRKG2
protein kinase cGMP-dependent 2
decreases expression
EXP
Vanadium results in decreased expression of PRKG2 mRNA
CTD
PMID:19000753
NCBI chr 4:81,087,370...81,217,836
Ensembl chr 4:81,087,370...81,215,222
G
PTGS1
prostaglandin-endoperoxide synthase 1
multiple interactions
EXP
[Vanadates results in increased abundance of Vanadium] which results in decreased expression of PTGS1 protein
CTD
PMID:25398544
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with [Vanadates results in increased abundance of Vanadium]] results in increased expression of PTGS2 protein
CTD
PMID:25398544
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTK2B
protein tyrosine kinase 2 beta
decreases expression
EXP
Vanadium results in decreased expression of PTK2B mRNA
CTD
PMID:19000753
NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,482...27,459,391
G
PTK6
protein tyrosine kinase 6
decreases expression
EXP
Vanadium results in decreased expression of PTK6 mRNA
CTD
PMID:19000753
NCBI chr20:63,528,001...63,537,376
Ensembl chr20:63,528,001...63,537,376
G
RPS6KB1
ribosomal protein S6 kinase B1
multiple interactions
ISO
PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]; Vanadium results in increased phosphorylation of and results in increased activity of RPS6KB1 protein
CTD
PMID:14971662
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
G
S1PR4
sphingosine-1-phosphate receptor 4
increases expression
EXP
Vanadium results in increased expression of S1PR4 mRNA
CTD
PMID:19000753
NCBI chr19:3,178,769...3,180,332
Ensembl chr19:3,172,346...3,180,332
G
SCN10A
sodium voltage-gated channel alpha subunit 10
increases expression
EXP
Vanadium results in increased expression of SCN10A mRNA
CTD
PMID:19000753
NCBI chr 3:38,696,807...38,816,217
Ensembl chr 3:38,696,802...38,816,286
G
SLC11A2
solute carrier family 11 member 2
decreases expression multiple interactions
ISO
Vanadium results in decreased expression of SLC11A2 mRNA; Vanadium results in decreased expression of SLC11A2 protein Metals inhibits the reaction [SLC11A2 protein results in increased transport of Vanadium]
CTD
PMID:15908475
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
G
SLC12A2
solute carrier family 12 member 2
increases expression
EXP
Vanadium results in increased expression of SLC12A2 mRNA
CTD
PMID:19000753
NCBI chr 5:128,083,766...128,189,677
Ensembl chr 5:128,083,766...128,189,677
G
SLC12A7
solute carrier family 12 member 7
decreases expression
EXP
Vanadium results in decreased expression of SLC12A7 mRNA
CTD
PMID:19000753
NCBI chr 5:1,050,384...1,155,899
Ensembl chr 5:1,050,384...1,112,063
G
SLC13A2
solute carrier family 13 member 2
decreases expression
EXP
Vanadium results in decreased expression of SLC13A2 mRNA
CTD
PMID:19000753
NCBI chr17:28,473,644...28,497,781
Ensembl chr17:28,473,293...28,497,781
G
SLC14A2
solute carrier family 14 member 2
increases expression
EXP
Vanadium results in increased expression of SLC14A2 mRNA
CTD
PMID:19000753
NCBI chr18:45,167,963...45,683,688
Ensembl chr18:45,212,995...45,683,688
G
SLC15A1
solute carrier family 15 member 1
decreases expression
EXP
Vanadium results in decreased expression of SLC15A1 mRNA
CTD
PMID:19000753
NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672
G
SLC16A5
solute carrier family 16 member 5
increases expression
EXP
Vanadium results in increased expression of SLC16A5 mRNA
CTD
PMID:19000753
NCBI chr17:75,087,385...75,110,149
Ensembl chr17:75,087,727...75,106,162
G
SLC17A5
solute carrier family 17 member 5
increases expression
EXP
Vanadium results in increased expression of SLC17A5 mRNA
CTD
PMID:19000753
NCBI chr 6:73,593,379...73,653,992
Ensembl chr 6:73,593,379...73,653,992
G
SLC18A3
solute carrier family 18 member A3
multiple interactions decreases expression
ISO
Nicotine inhibits the reaction [Vanadium results in decreased expression of SLC18A3 protein]
CTD
PMID:22119111
NCBI chr10:49,610,310...49,612,720
Ensembl chr10:49,610,310...49,612,720
G
SLC1A1
solute carrier family 1 member 1
decreases expression
EXP
Vanadium results in decreased expression of SLC1A1 mRNA
CTD
PMID:19000753
NCBI chr 9:4,490,468...4,587,469
Ensembl chr 9:4,490,468...4,587,469
G
SLC1A4
solute carrier family 1 member 4
decreases expression
EXP
Vanadium results in decreased expression of SLC1A4 mRNA
CTD
PMID:19000753
NCBI chr 2:64,988,479...65,023,865
Ensembl chr 2:64,988,477...65,023,865
G
SLC22A14
solute carrier family 22 member 14
increases expression
EXP
Vanadium results in increased expression of SLC22A14 mRNA
CTD
PMID:19000753
NCBI chr 3:38,278,832...38,318,575
Ensembl chr 3:38,282,294...38,318,575
G
SLC22A18AS
SLC22A18 antisense RNA
decreases expression
EXP
Vanadium results in decreased expression of SLC22A18AS mRNA
CTD
PMID:19000753
NCBI chr11:2,887,344...2,903,575
Ensembl chr11:2,887,344...2,903,813
G
SLC23A1
solute carrier family 23 member 1
increases expression
EXP
Vanadium results in increased expression of SLC23A1 mRNA
CTD
PMID:19000753
NCBI chr 5:139,367,196...139,385,676
Ensembl chr 5:139,367,196...139,384,553
G
SLC2A4
solute carrier family 2 member 4
decreases expression
EXP
Vanadium results in decreased expression of SLC2A4 mRNA
CTD
PMID:19000753
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
G
SLC30A3
solute carrier family 30 member 3
decreases expression
EXP
Vanadium results in decreased expression of SLC30A3 mRNA
CTD
PMID:19000753
NCBI chr 2:27,253,684...27,275,817
Ensembl chr 2:27,253,684...27,275,817
G
SLC30A4
solute carrier family 30 member 4
decreases expression
EXP
Vanadium results in decreased expression of SLC30A4 mRNA
CTD
PMID:19000753
NCBI chr15:45,479,606...45,522,755
Ensembl chr15:45,479,606...45,522,755
G
SLC31A1
solute carrier family 31 member 1
decreases expression
EXP
Vanadium results in decreased expression of SLC31A1 mRNA
CTD
PMID:19000753
NCBI chr 9:113,221,544...113,264,492
Ensembl chr 9:113,221,544...113,264,492
G
SLC39A1
solute carrier family 39 member 1
decreases expression
EXP
Vanadium results in decreased expression of SLC39A1 mRNA
CTD
PMID:19000753
NCBI chr 1:153,959,110...153,968,184
Ensembl chr 1:153,959,099...153,968,184
G
SLC6A9
solute carrier family 6 member 9
decreases expression
EXP
Vanadium results in decreased expression of SLC6A9 mRNA
CTD
PMID:19000753
NCBI chr 1:43,996,483...44,031,462
Ensembl chr 1:43,991,500...44,031,467
G
SLCO2B1
solute carrier organic anion transporter family member 2B1
increases expression
EXP
Vanadium results in increased expression of SLCO2B1 mRNA
CTD
PMID:19000753
NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
G
SLCO4A1
solute carrier organic anion transporter family member 4A1
decreases expression
EXP
Vanadium results in decreased expression of SLCO4A1 mRNA
CTD
PMID:19000753
NCBI chr20:62,642,503...62,690,740
Ensembl chr20:62,642,503...62,685,785
G
SMARCD1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1
decreases expression
EXP
Vanadium results in decreased expression of SMARCD1 mRNA
CTD
PMID:19000753
NCBI chr12:50,085,342...50,100,707
Ensembl chr12:50,085,200...50,100,707
G
STAT3
signal transducer and activator of transcription 3
multiple interactions
ISO
Vanadium promotes the reaction [LEP protein results in increased phosphorylation of STAT3 protein]
CTD
PMID:16195403
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,540
G
STK17A
serine/threonine kinase 17a
decreases expression
EXP
Vanadium results in decreased expression of STK17A mRNA
CTD
PMID:19000753
NCBI chr 7:43,583,108...43,627,379
Ensembl chr 7:43,582,758...43,650,713
G
STK38
serine/threonine kinase 38
increases expression
EXP
Vanadium results in increased expression of STK38 mRNA
CTD
PMID:19000753
NCBI chr 6:36,493,892...36,547,479
Ensembl chr 6:36,493,892...36,547,479
G
TAP2
transporter 2, ATP binding cassette subfamily B member
increases expression
EXP
Vanadium results in increased expression of TAP2 mRNA
CTD
PMID:19000753
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
G
TBXAS1
thromboxane A synthase 1
decreases expression
EXP
Vanadium results in decreased expression of TBXAS1 mRNA
CTD
PMID:19000753
NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325
G
TIMP1
TIMP metallopeptidase inhibitor 1
decreases expression
EXP
Vanadium results in decreased expression of TIMP1 mRNA
CTD
PMID:19000753
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TNF
tumor necrosis factor
multiple interactions
EXP ISO
[Titanium co-treated with Vanadium co-treated with Aluminum] results in increased expression of TNF mRNA [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in increased expression of TNF protein]
CTD
PMID:15862027 PMID:17408380
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TP53
tumor protein p53
multiple interactions increases activity
ISO EXP
Vanadium inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TP53 protein]; Vanadium promotes the reaction [2-Acetylaminofluorene results in increased expression of TP53 protein] Vanadium results in increased activity of TP53 protein
CTD
PMID:15565650 PMID:18155637 PMID:19000753
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TROAP
trophinin associated protein
increases expression
EXP
Vanadium results in increased expression of TROAP mRNA
CTD
PMID:19000753
NCBI chr12:49,323,255...49,331,731
Ensembl chr12:49,323,236...49,331,731
G
UCP1
uncoupling protein 1
multiple interactions
ISO
Vanadium promotes the reaction [LEP protein results in increased expression of UCP1 protein]
CTD
PMID:16195403
NCBI chr 4:140,559,431...140,568,961
Ensembl chr 4:140,559,431...140,568,961
G
USF1
upstream transcription factor 1
increases activity
EXP
Vanadium results in increased activity of USF1 protein
CTD
PMID:19000753
NCBI chr 1:161,039,251...161,045,977
Ensembl chr 1:161,039,251...161,045,977
G
VCAM1
vascular cell adhesion molecule 1
multiple interactions
EXP
[Particulate Matter results in increased abundance of Vanadium] which results in increased expression of VCAM1 protein
CTD
PMID:26732377
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
G
VDAC2
voltage dependent anion channel 2
increases expression
EXP
Vanadium results in increased expression of VDAC2 mRNA
CTD
PMID:19000753
NCBI chr10:75,210,170...75,231,448
Ensembl chr10:75,210,154...75,231,448
G
VEGFD
vascular endothelial growth factor D
increases expression
EXP
Vanadium results in increased expression of VEGFD mRNA
CTD
PMID:19000753
NCBI chr X:15,345,596...15,384,413
Ensembl chr X:15,345,596...15,384,413
G
ZAP70
zeta chain of T cell receptor associated protein kinase 70
decreases expression
EXP
Vanadium results in decreased expression of ZAP70 mRNA
CTD
PMID:19000753
NCBI chr 2:97,713,576...97,756,364
Ensembl chr 2:97,713,576...97,739,862
G
ACP3
acid phosphatase 3
decreases expression
EXP
vanadyl sulfate results in decreased expression of ACP3 mRNA
CTD
PMID:16330358
NCBI chr 3:132,317,407...132,368,302
Ensembl chr 3:132,317,369...132,368,302
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
NL-71-101 inhibits the reaction [vanadyl sulfate results in increased expression of ADIPOQ protein]; vanadyl sulfate results in increased expression of and results in increased secretion of ADIPOQ protein
CTD
PMID:16524741
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ALAS1
5'-aminolevulinate synthase 1
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in decreased expression of ALAS1 mRNA]
CTD
PMID:16684804
NCBI chr 3:52,198,083...52,214,327
Ensembl chr 3:52,198,086...52,214,327
G
ALB
albumin
increases expression
EXP
vanadyl sulfate results in increased expression of ALB mRNA
CTD
PMID:16330358
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ANGPTL1
angiopoietin like 1
increases expression
EXP
vanadyl sulfate results in increased expression of ANGPTL1 mRNA
CTD
PMID:16330358
NCBI chr 1:178,849,535...178,871,077
Ensembl chr 1:178,849,535...178,871,077
G
ANKRD1
ankyrin repeat domain 1
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of ANKRD1 mRNA]
CTD
PMID:16684804
NCBI chr10:90,912,096...90,921,087
Ensembl chr10:90,912,096...90,921,087
G
APOE
apolipoprotein E
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of APOE mRNA]
CTD
PMID:16684804
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
AQP7
aquaporin 7
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of AQP7 mRNA]
CTD
PMID:16684804
NCBI chr 9:33,383,191...33,402,568
Ensembl chr 9:33,383,179...33,402,682
G
ARNT
aryl hydrocarbon receptor nuclear translocator
decreases expression
EXP
vanadyl sulfate results in decreased expression of ARNT mRNA
CTD
PMID:16330358
NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
G
ARRDC3
arrestin domain containing 3
decreases expression
EXP
vanadyl sulfate results in decreased expression of ARRDC3 mRNA
CTD
PMID:16330358
NCBI chr 5:91,368,631...91,383,317
Ensembl chr 5:91,368,631...91,383,317
G
ARRDC4
arrestin domain containing 4
decreases expression
EXP
vanadyl sulfate results in decreased expression of ARRDC4 mRNA
CTD
PMID:16330358
NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833
G
ATF2
activating transcription factor 2
increases phosphorylation
EXP
vanadyl sulfate results in increased phosphorylation of ATF2 protein
CTD
PMID:9728050
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
G
BAX
BCL2 associated X, apoptosis regulator
decreases expression
EXP
vanadyl sulfate results in decreased expression of BAX protein
CTD
PMID:30407648
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
vanadyl sulfate results in decreased expression of BCL2 protein
CTD
PMID:30407648
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL6
BCL6 transcription repressor
decreases expression
EXP
vanadyl sulfate results in decreased expression of BCL6 mRNA
CTD
PMID:16330358
NCBI chr 3:187,721,377...187,745,468
Ensembl chr 3:187,721,377...187,745,725
G
BCOR
BCL6 corepressor
decreases expression
EXP
vanadyl sulfate results in decreased expression of BCOR mRNA
CTD
PMID:16330358
NCBI chr X:40,051,246...40,177,329
Ensembl chr X:40,049,815...40,177,329
G
C1QB
complement C1q B chain
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of C1QB mRNA]
CTD
PMID:16684804
NCBI chr 1:22,653,236...22,661,637
Ensembl chr 1:22,652,762...22,661,637
G
C4B
complement C4B (Chido blood group)
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of C4B mRNA]
CTD
PMID:16684804
NCBI chr 6:32,014,795...32,035,418
Ensembl chr 6:32,014,795...32,035,418
G
CACNG2
calcium voltage-gated channel auxiliary subunit gamma 2
increases expression
EXP
vanadyl sulfate results in increased expression of CACNG2 mRNA
CTD
PMID:16330358
NCBI chr22:36,560,857...36,703,752
Ensembl chr22:36,560,857...36,703,752
G
CALM1
calmodulin 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of CALM1 mRNA
CTD
PMID:16330358
NCBI chr14:90,396,502...90,408,268
Ensembl chr14:90,396,502...90,408,268
G
CASP1
caspase 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of CASP1 protein
CTD
PMID:30407648
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CASP3
caspase 3
decreases cleavage
EXP
vanadyl sulfate results in decreased cleavage of CASP3 protein
CTD
PMID:30407648
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP9
caspase 9
decreases expression
EXP
vanadyl sulfate results in decreased expression of CASP9 protein
CTD
PMID:30407648
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CAT
catalase
multiple interactions
EXP
CAT protein inhibits the reaction [vanadyl sulfate results in increased activity of RELA protein]; CAT protein inhibits the reaction [vanadyl sulfate results in increased degradation of NFKBIA protein]
CTD
PMID:10873158
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCDC85B
coiled-coil domain containing 85B
increases expression
EXP
vanadyl sulfate results in increased expression of CCDC85B mRNA
CTD
PMID:16330358
NCBI chr11:65,890,673...65,891,635
Ensembl chr11:65,890,673...65,891,635
G
CCL2
C-C motif chemokine ligand 2
increases expression multiple interactions
EXP ISO
vanadyl sulfate results in increased expression of CCL2 mRNA vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA]
CTD
PMID:16330358 PMID:16684804
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL5
C-C motif chemokine ligand 5
increases expression
EXP
vanadyl sulfate results in increased expression of CCL5 protein
CTD
PMID:18684396
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCNF
cyclin F
decreases expression
EXP
vanadyl sulfate results in decreased expression of CCNF mRNA
CTD
PMID:16330358
NCBI chr16:2,429,447...2,458,854
Ensembl chr16:2,429,394...2,458,854
G
CINP
cyclin dependent kinase 2 interacting protein
decreases expression
EXP
vanadyl sulfate results in decreased expression of CINP mRNA
CTD
PMID:16330358
NCBI chr14:102,348,282...102,362,890
Ensembl chr14:102,341,102...102,362,916
G
CIRBP
cold inducible RNA binding protein
decreases expression
EXP
vanadyl sulfate results in decreased expression of CIRBP mRNA
CTD
PMID:16330358
NCBI chr19:1,269,332...1,274,880
Ensembl chr19:1,259,384...1,274,880
G
CITED2
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CITED2 mRNA]
CTD
PMID:16684804
NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648
G
CKMT2
creatine kinase, mitochondrial 2
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in decreased expression of CKMT2 mRNA]
CTD
PMID:16684804
NCBI chr 5:81,233,322...81,266,398
Ensembl chr 5:81,233,320...81,266,398
G
CLDN1
claudin 1
increases expression
EXP
vanadyl sulfate results in increased expression of CLDN1 mRNA
CTD
PMID:16330358
NCBI chr 3:190,305,707...190,322,446
Ensembl chr 3:190,305,707...190,322,446
G
CLDN4
claudin 4
increases expression
EXP
vanadyl sulfate results in increased expression of CLDN4 mRNA
CTD
PMID:16330358
NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690
G
CPT1A
carnitine palmitoyltransferase 1A
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CPT1A mRNA]
CTD
PMID:16684804
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
G
CPVL
carboxypeptidase vitellogenic like
increases expression
EXP
vanadyl sulfate results in increased expression of CPVL mRNA
CTD
PMID:16330358
NCBI chr 7:28,994,636...29,195,451
Ensembl chr 7:28,995,235...29,195,451
G
CRH
corticotropin releasing hormone
decreases expression
EXP
vanadyl sulfate results in decreased expression of CRH mRNA
CTD
PMID:16330358
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
G
CSF2
colony stimulating factor 2
increases expression
EXP
vanadyl sulfate results in increased expression of CSF2 protein
CTD
PMID:18684396
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CSNK1D
casein kinase 1 delta
increases expression
EXP
vanadyl sulfate results in increased expression of CSNK1D mRNA
CTD
PMID:16330358
NCBI chr17:82,239,019...82,273,750
Ensembl chr17:82,239,023...82,273,700
G
CSRP3
cysteine and glycine rich protein 3
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CSRP3 mRNA]
CTD
PMID:16684804
NCBI chr11:19,182,030...19,201,983
Ensembl chr11:19,182,030...19,210,571
G
CTSG
cathepsin G
increases expression
EXP
vanadyl sulfate results in increased expression of CTSG mRNA
CTD
PMID:16330358
NCBI chr14:24,573,518...24,576,250
Ensembl chr14:24,573,518...24,576,250
G
CTSS
cathepsin S
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CTSS mRNA]
CTD
PMID:16684804
NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957
G
CXCL1
C-X-C motif chemokine ligand 1
increases expression
EXP
vanadyl sulfate results in increased expression of CXCL1 mRNA
CTD
PMID:16330358
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL2
C-X-C motif chemokine ligand 2
increases expression
EXP
vanadyl sulfate results in increased expression of CXCL2 protein
CTD
PMID:18684396
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL3
C-X-C motif chemokine ligand 3
increases expression
EXP
vanadyl sulfate results in increased expression of CXCL3 mRNA
CTD
PMID:16330358
NCBI chr 4:74,036,589...74,038,689
Ensembl chr 4:74,036,589...74,038,807
G
CXCL8
C-X-C motif chemokine ligand 8
increases secretion increases expression multiple interactions
EXP
vanadyl sulfate results in increased secretion of CXCL8 protein vanadyl sulfate results in increased expression of CXCL8 mRNA; vanadyl sulfate results in increased expression of CXCL8 protein NFKBIA protein mutant form inhibits the reaction [vanadyl sulfate results in increased expression of CXCL8 mRNA]
CTD
PMID:9728050 PMID:10521501 PMID:16330358 PMID:18684396
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYBB
cytochrome b-245 beta chain
decreases expression
EXP
vanadyl sulfate results in decreased expression of CYBB mRNA
CTD
PMID:16330358
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
G
CYP11A1
cytochrome P450 family 11 subfamily A member 1
increases expression
EXP
vanadyl sulfate results in increased expression of CYP11A1 mRNA
CTD
PMID:16330358
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
G
CYP3A7
cytochrome P450 family 3 subfamily A member 7
increases expression
EXP
vanadyl sulfate results in increased expression of CYP3A7 mRNA
CTD
PMID:16330358
NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
G
DDX39B
DExD-box helicase 39B
decreases expression
EXP
vanadyl sulfate results in decreased expression of DDX39B mRNA
CTD
PMID:16330358
NCBI chr 6:31,530,226...31,542,003
Ensembl chr 6:31,530,219...31,542,448
G
DECR1
2,4-dienoyl-CoA reductase 1
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of DECR1 mRNA]
CTD
PMID:16684804
NCBI chr 8:90,001,477...90,053,633
Ensembl chr 8:90,001,405...90,053,633
G
DENR
density regulated re-initiation and release factor
decreases expression
EXP
vanadyl sulfate results in decreased expression of DENR mRNA
CTD
PMID:16330358
NCBI chr12:122,752,824...122,771,064
Ensembl chr12:122,752,824...122,771,064
G
DRP2
dystrophin related protein 2
increases expression
EXP
vanadyl sulfate results in increased expression of DRP2 mRNA
CTD
PMID:16330358
NCBI chr X:101,219,786...101,264,502
Ensembl chr X:101,219,769...101,264,502
G
DUSP1
dual specificity phosphatase 1
increases expression
EXP
vanadyl sulfate results in increased expression of DUSP1 mRNA
CTD
PMID:16330358
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP21
dual specificity phosphatase 21
increases expression
EXP
vanadyl sulfate results in increased expression of DUSP21 mRNA
CTD
PMID:16330358
NCBI chr X:44,844,021...44,844,888
Ensembl chr X:44,844,021...44,844,888
G
DUSP5
dual specificity phosphatase 5
increases expression
EXP
vanadyl sulfate results in increased expression of DUSP5 mRNA
CTD
PMID:16330358
NCBI chr10:110,497,907...110,511,533
Ensembl chr10:110,497,907...110,511,533
G
EDN1
endothelin 1
increases expression
EXP
vanadyl sulfate results in increased expression of EDN1 mRNA
CTD
PMID:16330358
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
EGFR
epidermal growth factor receptor
increases phosphorylation
EXP
vanadyl sulfate results in increased phosphorylation of EGFR protein
CTD
PMID:10564177 PMID:11943669
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EIF4EBP1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of EIF4EBP1 mRNA]
CTD
PMID:16684804
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
G
ELK1
ETS transcription factor ELK1
increases activity multiple interactions
EXP
vanadyl sulfate results in increased activity of ELK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [vanadyl sulfate results in increased activity of ELK1 protein]
CTD
PMID:10564177
NCBI chr X:47,635,520...47,650,604
Ensembl chr X:47,635,521...47,650,604
G
ERRFI1
ERBB receptor feedback inhibitor 1
increases expression
EXP
vanadyl sulfate results in increased expression of ERRFI1 mRNA
CTD
PMID:16330358
NCBI chr 1:8,011,727...8,026,309
Ensembl chr 1:8,004,404...8,026,309
G
FASLG
Fas ligand
decreases expression
EXP
vanadyl sulfate results in decreased expression of FASLG protein
CTD
PMID:30407648
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FBXO5
F-box protein 5
decreases expression
EXP
vanadyl sulfate results in decreased expression of FBXO5 mRNA
CTD
PMID:16330358
NCBI chr 6:152,970,535...152,983,579
Ensembl chr 6:152,970,519...152,983,579
G
FCGR2A
Fc gamma receptor IIa
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of FCGR3 mRNA]
CTD
PMID:16684804
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
FGD6
FYVE, RhoGEF and PH domain containing 6
increases expression
EXP
vanadyl sulfate results in increased expression of FGD6 mRNA
CTD
PMID:16330358
NCBI chr12:95,076,749...95,217,467
Ensembl chr12:95,076,749...95,217,482
G
FGFR2
fibroblast growth factor receptor 2
increases expression
EXP
vanadyl sulfate results in increased expression of FGFR2 mRNA
CTD
PMID:16330358
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
vanadyl sulfate results in increased expression of FOS mRNA
CTD
PMID:16330358
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FYB1
FYN binding protein 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of FYB1 mRNA
CTD
PMID:16330358
NCBI chr 5:39,105,252...39,274,528
Ensembl chr 5:39,105,252...39,274,528
G
GALT
galactose-1-phosphate uridylyltransferase
decreases expression
EXP
vanadyl sulfate results in decreased expression of GALT mRNA
CTD
PMID:16330358
NCBI chr 9:34,646,675...34,651,035
Ensembl chr 9:34,638,133...34,651,035
G
GCNT2
glucosaminyl (N-acetyl) transferase 2 (I blood group)
increases expression
EXP
vanadyl sulfate results in increased expression of GCNT2 mRNA
CTD
PMID:16330358
NCBI chr 6:10,521,351...10,629,368
Ensembl chr 6:10,492,223...10,629,368
G
GPR137B
G protein-coupled receptor 137B
decreases expression
EXP
vanadyl sulfate results in decreased expression of GPR137B mRNA
CTD
PMID:16330358
NCBI chr 1:236,142,539...236,208,907
Ensembl chr 1:236,142,505...236,221,865
G
GSTM2
glutathione S-transferase mu 2
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of GSTM2 mRNA]
CTD
PMID:16684804
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
GSTM5
glutathione S-transferase mu 5
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of GSTM5 mRNA]
CTD
PMID:16684804
NCBI chr 1:109,711,751...109,718,268
Ensembl chr 1:109,711,780...109,775,428
G
HAL
histidine ammonia-lyase
increases expression
EXP
vanadyl sulfate results in increased expression of HAL mRNA
CTD
PMID:16330358
NCBI chr12:95,972,662...95,996,344
Ensembl chr12:95,972,662...95,996,365
G
HBEGF
heparin binding EGF like growth factor
increases expression
EXP
vanadyl sulfate results in increased expression of HBEGF mRNA
CTD
PMID:18684396
NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
G
HMGCS2
3-hydroxy-3-methylglutaryl-CoA synthase 2
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of HMGCS2 mRNA]
CTD
PMID:16684804
NCBI chr 1:119,747,996...119,768,932
Ensembl chr 1:119,748,002...119,768,905
G
HNRNPA2B1
heterogeneous nuclear ribonucleoprotein A2/B1
decreases expression
EXP
vanadyl sulfate results in decreased expression of HNRNPA2B1 mRNA
CTD
PMID:16330358
NCBI chr 7:26,189,927...26,200,746
Ensembl chr 7:26,171,151...26,201,529
G
HOXD9
homeobox D9
increases expression
EXP
vanadyl sulfate results in increased expression of HOXD9 mRNA
CTD
PMID:16330358
NCBI chr 2:176,122,719...176,124,937
Ensembl chr 2:176,122,719...176,124,937
G
HS3ST1
heparan sulfate-glucosamine 3-sulfotransferase 1
increases expression
EXP
vanadyl sulfate results in increased expression of HS3ST1 mRNA
CTD
PMID:16330358
NCBI chr 4:11,393,150...11,434,327
Ensembl chr 4:11,393,150...11,429,564
G
ICA1
islet cell autoantigen 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of ICA1 mRNA
CTD
PMID:16330358
NCBI chr 7:8,113,184...8,262,555
Ensembl chr 7:8,113,184...8,262,687
G
ICAM2
intercellular adhesion molecule 2
increases expression
EXP
vanadyl sulfate results in increased expression of ICAM2 mRNA
CTD
PMID:16330358
NCBI chr17:64,002,595...64,020,633
Ensembl chr17:64,002,594...64,020,634
G
ID3
inhibitor of DNA binding 3
decreases expression
EXP
vanadyl sulfate results in decreased expression of ID3 mRNA
CTD
PMID:16330358
NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501
G
IFNE
interferon epsilon
increases expression
EXP
vanadyl sulfate results in increased expression of IFNE mRNA
CTD
PMID:16330358
NCBI chr 9:21,480,839...21,482,313
Ensembl chr 9:21,480,839...21,482,313
G
IL1A
interleukin 1 alpha
increases expression
EXP
vanadyl sulfate results in increased expression of IL1A mRNA
CTD
PMID:16330358
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
multiple interactions
ISO
vanadyl sulfate affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
CTD
PMID:16217019
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1R1
interleukin 1 receptor type 1
increases expression
ISO
vanadyl sulfate results in increased expression of IL1R1 mRNA
CTD
PMID:16217019
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
G
IL1R2
interleukin 1 receptor type 2
increases expression
ISO
vanadyl sulfate results in increased expression of IL1R2 mRNA
CTD
PMID:16217019
NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544
G
IL36G
interleukin 36 gamma
increases expression
EXP
vanadyl sulfate results in increased expression of IL36G mRNA
CTD
PMID:16330358
NCBI chr 2:112,978,006...112,985,658
Ensembl chr 2:112,973,203...112,985,658
G
IL6
interleukin 6
increases expression multiple interactions
EXP ISO
vanadyl sulfate results in increased expression of IL6 protein vanadyl sulfate affects the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
CTD
PMID:16217019 PMID:18684396
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IMPA2
inositol monophosphatase 2
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of IMPA2 mRNA]
CTD
PMID:16684804
NCBI chr18:11,981,507...12,030,877
Ensembl chr18:11,981,025...12,030,877
G
ITPR3
inositol 1,4,5-trisphosphate receptor type 3
increases expression
EXP
vanadyl sulfate results in increased expression of ITPR3 mRNA
CTD
PMID:16330358
NCBI chr 6:33,621,322...33,696,562
Ensembl chr 6:33,620,365...33,696,574
G
JAM2
junctional adhesion molecule 2
increases expression
EXP
vanadyl sulfate results in increased expression of JAM2 mRNA
CTD
PMID:16330358
NCBI chr21:25,639,258...25,717,562
Ensembl chr21:25,639,258...25,717,562
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases phosphorylation
EXP
vanadyl sulfate results in increased phosphorylation of JUN protein
CTD
PMID:9728050
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KBTBD6
kelch repeat and BTB domain containing 6
decreases expression
EXP
vanadyl sulfate results in decreased expression of KBTBD6 mRNA
CTD
PMID:16330358
NCBI chr13:41,127,569...41,132,802
Ensembl chr13:41,127,569...41,132,802
G
KCTD6
potassium channel tetramerization domain containing 6
decreases expression
EXP
vanadyl sulfate results in decreased expression of KCTD6 mRNA
CTD
PMID:16330358
NCBI chr 3:58,492,096...58,502,360
Ensembl chr 3:58,492,096...58,502,360
G
KDM4D
lysine demethylase 4D
increases expression
EXP
vanadyl sulfate results in increased expression of KDM4D mRNA
CTD
PMID:16330358
NCBI chr11:94,973,709...94,999,519
Ensembl chr11:94,973,709...94,999,519
G
KLHL41
kelch like family member 41
increases expression
EXP
vanadyl sulfate results in increased expression of KLHL41 mRNA
CTD
PMID:16330358
NCBI chr 2:169,509,702...169,526,258
Ensembl chr 2:169,509,702...169,526,258
G
KRT36
keratin 36
increases expression
EXP
vanadyl sulfate results in increased expression of KRT36 mRNA
CTD
PMID:16330358
NCBI chr17:41,486,136...41,489,910
Ensembl chr17:41,486,136...41,492,546
G
KRT86
keratin 86
increases expression
EXP
vanadyl sulfate results in increased expression of KRT86 mRNA
CTD
PMID:16330358
NCBI chr12:52,274,645...52,309,163
Ensembl chr12:52,249,300...52,309,163
G
LGALS3
galectin 3
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA]
CTD
PMID:16684804
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
G
LHX9
LIM homeobox 9
decreases expression
EXP
vanadyl sulfate results in decreased expression of LHX9 mRNA
CTD
PMID:16330358
NCBI chr 1:197,912,464...197,935,478
Ensembl chr 1:197,911,902...197,935,478
G
LIF
LIF interleukin 6 family cytokine
increases expression
EXP
vanadyl sulfate results in increased expression of LIF mRNA
CTD
PMID:16330358
NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759
G
LINS1
lines homolog 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of LINS1 mRNA
CTD
PMID:16330358
NCBI chr15:100,566,924...100,602,184
Ensembl chr15:100,559,369...100,603,230
G
LIPE
lipase E, hormone sensitive type
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LIPE mRNA]
CTD
PMID:16684804
NCBI chr19:42,401,514...42,427,388
Ensembl chr19:42,401,514...42,427,388
G
LYZ
lysozyme
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LYZ mRNA]
CTD
PMID:16684804
NCBI chr12:69,348,381...69,354,234
Ensembl chr12:69,348,381...69,354,234
G
MAP2K1
mitogen-activated protein kinase kinase 1
multiple interactions increases phosphorylation
EXP
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAP2K1 protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAP2K1 protein]; vanadyl sulfate results in increased phosphorylation of and results in increased activity of MAP2K1 protein
CTD
PMID:10564177 PMID:11943669
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
G
MAP2K2
mitogen-activated protein kinase kinase 2
multiple interactions increases phosphorylation
EXP
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAP2K2 protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAP2K2 protein]; vanadyl sulfate results in increased phosphorylation of and results in increased activity of MAP2K2 protein
CTD
PMID:10564177 PMID:11943669
NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions increases phosphorylation
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAPK1 protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAPK1 protein]; vanadyl sulfate results in increased phosphorylation of and results in increased activity of MAPK1 protein
CTD
PMID:9728050 PMID:10564177 PMID:11943669
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK14
mitogen-activated protein kinase 14
decreases expression
EXP
vanadyl sulfate results in decreased expression of MAPK14 mRNA
CTD
PMID:16330358
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions increases phosphorylation
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAPK3 protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAPK3 protein]; vanadyl sulfate results in increased phosphorylation of and results in increased activity of MAPK3 protein
CTD
PMID:10564177 PMID:11943669
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MCHR1
melanin concentrating hormone receptor 1
increases expression
EXP
vanadyl sulfate results in increased expression of MCHR1 mRNA
CTD
PMID:16330358
NCBI chr22:40,679,484...40,682,812
Ensembl chr22:40,679,273...40,682,812
G
MMP1
matrix metallopeptidase 1
increases expression
EXP
vanadyl sulfate results in increased expression of MMP1 mRNA; vanadyl sulfate results in increased expression of MMP1 protein
CTD
PMID:18684396
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP25
matrix metallopeptidase 25
increases expression
EXP
vanadyl sulfate results in increased expression of MMP25 mRNA
CTD
PMID:16330358
NCBI chr16:3,046,561...3,060,726
Ensembl chr16:3,046,062...3,060,726
G
MRAS
muscle RAS oncogene homolog
multiple interactions increases activity
EXP
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [vanadyl sulfate results in increased activity of MRAS protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased activity of and affects the localization of [RELA protein binds to NFKB1 protein]]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased degradation of NFKBIA protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAP2K1 protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAP2K2 protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAPK1 protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased phosphorylation of MAPK3 protein]
CTD
PMID:11943669
NCBI chr 3:138,347,648...138,405,535
Ensembl chr 3:138,347,648...138,405,534
G
MT1A
metallothionein 1A
multiple interactions increases expression
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of MT1A mRNA] vanadyl sulfate results in increased expression of MT1A mRNA
CTD
PMID:16684804 PMID:19679144
NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087
G
MYH3
myosin heavy chain 3
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of MYH3 mRNA]
CTD
PMID:16684804
NCBI chr17:10,628,532...10,678,417
Ensembl chr17:10,628,526...10,657,309
G
MYO3B
myosin IIIB
decreases expression
EXP
vanadyl sulfate results in decreased expression of MYO3B mRNA
CTD
PMID:16330358
NCBI chr 2:170,178,147...170,655,167
Ensembl chr 2:170,178,145...170,655,171
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions
EXP
MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased activity of and affects the localization of [RELA protein binds to NFKB1 protein]]; vanadyl sulfate results in increased activity of and affects the localization of [RELA protein binds to NFKB1 protein]
CTD
PMID:11943669
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFKBIA
NFKB inhibitor alpha
multiple interactions increases degradation increases phosphorylation
EXP ISO
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [vanadyl sulfate results in increased degradation of NFKBIA protein]; CAT protein inhibits the reaction [vanadyl sulfate results in increased degradation of NFKBIA protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased degradation of NFKBIA protein]; NFKBIA protein mutant form inhibits the reaction [vanadyl sulfate affects the localization of RELA protein]; NFKBIA protein mutant form inhibits the reaction [vanadyl sulfate results in increased expression of CXCL8 mRNA] vanadyl sulfate results in increased phosphorylation of NFKBIA protein vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of NFKBIA mRNA]
CTD
PMID:10521501 PMID:10873158 PMID:11943669 PMID:16684804
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NFKBIB
NFKB inhibitor beta
increases degradation
EXP
vanadyl sulfate results in increased degradation of NFKBIB protein
CTD
PMID:10521501
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
G
NPY
neuropeptide Y
increases expression
ISO
vanadyl sulfate results in increased expression of NPY mRNA
CTD
PMID:11294500
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
P2RY2
purinergic receptor P2Y2
decreases expression
EXP
vanadyl sulfate results in decreased expression of P2RY2 mRNA
CTD
PMID:16330358
NCBI chr11:73,218,281...73,242,427
Ensembl chr11:73,218,281...73,242,427
G
PAK6
p21 (RAC1) activated kinase 6
decreases expression
EXP
vanadyl sulfate results in decreased expression of PAK6 mRNA
CTD
PMID:16330358
NCBI chr15:40,239,063...40,277,487
Ensembl chr15:40,217,428...40,277,487
G
PDCD6
programmed cell death 6
increases expression
EXP
vanadyl sulfate results in increased expression of PDCD6 mRNA
CTD
PMID:16330358
NCBI chr 5:271,646...314,974
Ensembl chr 5:271,621...314,974
G
PDE4DIP
phosphodiesterase 4D interacting protein
increases expression
EXP
vanadyl sulfate results in increased expression of PDE4DIP mRNA
CTD
PMID:16330358
NCBI chr 1:148,808,434...149,033,016
Ensembl chr 1:148,808,140...149,048,286
G
PDK2
pyruvate dehydrogenase kinase 2
increases expression
EXP
vanadyl sulfate results in increased expression of PDK2 mRNA
CTD
PMID:16330358
NCBI chr17:50,094,737...50,112,152
Ensembl chr17:50,094,737...50,112,152
G
PDLIM3
PDZ and LIM domain 3
increases expression
EXP
vanadyl sulfate results in increased expression of PDLIM3 mRNA
CTD
PMID:16330358
NCBI chr 4:185,500,660...185,535,507
Ensembl chr 4:185,500,660...185,535,507
G
PDXP
pyridoxal phosphatase
decreases expression
EXP
vanadyl sulfate results in decreased expression of PDXP mRNA
CTD
PMID:16330358
NCBI chr22:37,658,723...37,666,932
Ensembl chr22:37,658,723...37,666,932
G
PLA2G12B
phospholipase A2 group XIIB
increases expression
EXP
vanadyl sulfate results in increased expression of PLA2G12B mRNA
CTD
PMID:16330358
NCBI chr10:72,934,762...72,954,806
Ensembl chr10:72,934,762...72,954,806
G
PLA2G1B
phospholipase A2 group IB
increases expression
EXP
vanadyl sulfate results in increased expression of PLA2G1B mRNA
CTD
PMID:16330358
NCBI chr12:120,322,115...120,327,779
Ensembl chr12:120,322,115...120,327,779
G
PLAUR
plasminogen activator, urokinase receptor
increases expression
EXP
vanadyl sulfate results in increased expression of PLAUR mRNA
CTD
PMID:16330358
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PLEKHB1
pleckstrin homology domain containing B1
increases expression
EXP
vanadyl sulfate results in increased expression of PLEKHB1 mRNA
CTD
PMID:16330358
NCBI chr11:73,646,581...73,662,819
Ensembl chr11:73,646,178...73,662,819
G
PML
PML nuclear body scaffold
decreases expression
EXP
vanadyl sulfate results in decreased expression of PML mRNA
CTD
PMID:16330358
NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827
G
PMS2P5
PMS1 homolog 2, mismatch repair system component pseudogene 5
decreases expression
EXP
vanadyl sulfate results in decreased expression of PMS2P5 mRNA
CTD
PMID:16330358
NCBI chr 7:74,890,768...74,921,138
Ensembl chr 7:74,894,116...74,897,835
G
POLR3G
RNA polymerase III subunit G
increases expression
EXP
vanadyl sulfate results in increased expression of POLR3G mRNA
CTD
PMID:16330358
NCBI chr 5:90,473,929...90,514,557
Ensembl chr 5:90,471,748...90,514,557
G
PPEF2
protein phosphatase with EF-hand domain 2
increases expression
EXP
vanadyl sulfate results in increased expression of PPEF2 mRNA
CTD
PMID:16330358
NCBI chr 4:75,859,867...75,902,452
Ensembl chr 4:75,859,864...75,902,571
G
PPP1R10
protein phosphatase 1 regulatory subunit 10
increases expression
EXP
vanadyl sulfate results in increased expression of PPP1R10 mRNA
CTD
PMID:16330358
NCBI chr 6:30,600,413...30,617,243
Ensembl chr 6:30,600,413...30,618,612
G
PRDM1
PR/SET domain 1
increases expression
EXP
vanadyl sulfate results in increased expression of PRDM1 mRNA
CTD
PMID:16330358
NCBI chr 6:105,992,690...106,109,938
Ensembl chr 6:105,993,463...106,109,939
G
PTGS2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
vanadyl sulfate results in increased expression of PTGS2 mRNA
CTD
PMID:16330358
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTH
parathyroid hormone
decreases expression
EXP
vanadyl sulfate results in decreased expression of PTH mRNA
CTD
PMID:16330358
NCBI chr11:13,492,054...13,496,181
Ensembl chr11:13,492,054...13,496,181
G
PTPN1
protein tyrosine phosphatase non-receptor type 1
decreases activity
EXP
vanadyl sulfate results in decreased activity of PTPN1 protein
CTD
PMID:10460753
NCBI chr20:50,510,383...50,585,241
Ensembl chr20:50,510,321...50,585,241
G
PTPRE
protein tyrosine phosphatase receptor type E
increases expression
EXP
vanadyl sulfate results in increased expression of PTPRE mRNA
CTD
PMID:16330358
NCBI chr10:127,907,103...128,085,855
Ensembl chr10:127,907,103...128,085,855
G
RARA
retinoic acid receptor alpha
decreases expression
EXP
vanadyl sulfate results in decreased expression of RARA mRNA
CTD
PMID:16330358
NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643
G
RARS2
arginyl-tRNA synthetase 2, mitochondrial
increases expression
EXP
vanadyl sulfate results in increased expression of RARS2 mRNA
CTD
PMID:16330358
NCBI chr 6:87,513,938...87,589,987
Ensembl chr 6:87,513,459...87,590,028
G
RCE1
Ras converting CAAX endopeptidase 1
increases expression
EXP
vanadyl sulfate results in increased expression of RCE1 mRNA
CTD
PMID:16330358
NCBI chr11:66,843,441...66,846,552
Ensembl chr11:66,842,835...66,846,552
G
RCHY1
ring finger and CHY zinc finger domain containing 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of RCHY1 mRNA
CTD
PMID:16330358
NCBI chr 4:75,479,033...75,514,715
Ensembl chr 4:75,479,033...75,514,764
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
CAT protein inhibits the reaction [vanadyl sulfate results in increased activity of RELA protein]; MRAS mutant form inhibits the reaction [vanadyl sulfate results in increased activity of and affects the localization of [RELA protein binds to NFKB1 protein]]; NFKBIA protein mutant form inhibits the reaction [vanadyl sulfate affects the localization of RELA protein]; SB 203580 inhibits the reaction [vanadyl sulfate results in increased activity of RELA protein]; vanadyl sulfate affects the localization of and results in increased activity of RELA protein; vanadyl sulfate results in increased activity of and affects the localization of [RELA protein binds to NFKB1 protein]; vanadyl sulfate results in increased localization of and results in increased activity of RELA protein
CTD
PMID:10521501 PMID:10873158 PMID:11943669
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RGS2
regulator of G protein signaling 2
increases expression
EXP
vanadyl sulfate results in increased expression of RGS2 mRNA
CTD
PMID:16330358
NCBI chr 1:192,809,039...192,812,275
Ensembl chr 1:192,809,039...192,812,275
G
RHOJ
ras homolog family member J
increases expression
EXP
vanadyl sulfate results in increased expression of RHOJ mRNA
CTD
PMID:16330358
NCBI chr14:63,204,443...63,293,508
Ensembl chr14:63,204,114...63,293,508
G
RIMS3
regulating synaptic membrane exocytosis 3
decreases expression
EXP
vanadyl sulfate results in decreased expression of RIMS3 mRNA
CTD
PMID:16330358
NCBI chr 1:40,620,680...40,692,066
Ensembl chr 1:40,620,680...40,665,682
G
RPL13
ribosomal protein L13
increases expression
EXP
vanadyl sulfate results in increased expression of RPL13 mRNA
CTD
PMID:16330358
NCBI chr16:89,560,657...89,566,829
Ensembl chr16:89,560,677...89,564,542
G
RPL18A
ribosomal protein L18a
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of RPL18A mRNA]
CTD
PMID:16684804
NCBI chr19:17,859,910...17,863,319
Ensembl chr19:17,859,910...17,864,153
G
RPS3
ribosomal protein S3
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of RPS3 mRNA]
CTD
PMID:16684804
NCBI chr11:75,399,518...75,422,302
Ensembl chr11:75,399,515...75,422,280
G
RRAD
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of RRAD mRNA]
CTD
PMID:16684804
NCBI chr16:66,921,685...66,925,535
Ensembl chr16:66,921,685...66,925,535
G
S100A6
S100 calcium binding protein A6
decreases expression
EXP
vanadyl sulfate results in decreased expression of S100A6 mRNA
CTD
PMID:16330358
NCBI chr 1:153,534,599...153,535,991
Ensembl chr 1:153,534,599...153,536,244
G
S1PR3
sphingosine-1-phosphate receptor 3
increases expression
EXP
vanadyl sulfate results in increased expression of S1PR3 mRNA
CTD
PMID:16330358
NCBI chr 9:88,990,863...89,005,155
Ensembl chr 9:88,990,863...89,005,155
G
SCARF2
scavenger receptor class F member 2
decreases expression
EXP
vanadyl sulfate results in decreased expression of SCARF2 mRNA
CTD
PMID:16330358
NCBI chr22:20,424,584...20,437,825
Ensembl chr22:20,424,584...20,437,826
G
SDCCAG8
SHH signaling and ciliogenesis regulator SDCCAG8
decreases expression
EXP
vanadyl sulfate results in decreased expression of SDCCAG8 mRNA
CTD
PMID:16330358
NCBI chr 1:243,256,041...243,500,091
Ensembl chr 1:243,256,034...243,500,091
G
SERPINB2
serpin family B member 2
increases expression
EXP
vanadyl sulfate results in increased expression of SERPINB2 mRNA
CTD
PMID:16330358
NCBI chr18:63,887,705...63,903,888
Ensembl chr18:63,871,692...63,903,888
G
SERPINI2
serpin family I member 2
increases expression
EXP
vanadyl sulfate results in increased expression of SERPINI2 mRNA
CTD
PMID:16330358
NCBI chr 3:167,441,933...167,476,963
Ensembl chr 3:167,441,914...167,478,972
G
SIGLEC8
sialic acid binding Ig like lectin 8
increases expression
EXP
vanadyl sulfate results in increased expression of SIGLEC8 mRNA
CTD
PMID:16330358
NCBI chr19:51,450,997...51,458,454
Ensembl chr19:51,450,847...51,458,456
G
SIPA1L3
signal induced proliferation associated 1 like 3
increases expression
EXP
vanadyl sulfate results in increased expression of SIPA1L3 mRNA
CTD
PMID:16330358
NCBI chr19:37,907,208...38,208,369
Ensembl chr19:37,907,208...38,208,369
G
SIX1
SIX homeobox 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of SIX1 mRNA
CTD
PMID:16330358
NCBI chr14:60,643,421...60,649,477
Ensembl chr14:60,643,421...60,658,259
G
SIX2
SIX homeobox 2
decreases expression
EXP
vanadyl sulfate results in decreased expression of SIX2 mRNA
CTD
PMID:16330358
NCBI chr 2:45,005,182...45,009,452
Ensembl chr 2:45,005,182...45,009,452
G
SLC13A3
solute carrier family 13 member 3
increases expression
EXP
vanadyl sulfate results in increased expression of SLC13A3 mRNA
CTD
PMID:16330358
NCBI chr20:46,557,828...46,684,485
Ensembl chr20:46,557,823...46,684,467
G
SLC22A16
solute carrier family 22 member 16
increases expression
EXP
vanadyl sulfate results in increased expression of SLC22A16 mRNA
CTD
PMID:16330358
NCBI chr 6:110,424,687...110,476,613
Ensembl chr 6:110,424,687...110,476,641
G
SLC26A3
solute carrier family 26 member 3
decreases expression
EXP
vanadyl sulfate results in decreased expression of SLC26A3 mRNA
CTD
PMID:16330358
NCBI chr 7:107,765,469...107,803,223
Ensembl chr 7:107,765,467...107,803,225
G
SLC27A1
solute carrier family 27 member 1
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of SLC27A1 mRNA]
CTD
PMID:16684804
NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168
G
SMAD4
SMAD family member 4
decreases expression
EXP
vanadyl sulfate results in decreased expression of SMAD4 mRNA
CTD
PMID:16330358
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
G
SNCG
synuclein gamma
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of SNCG mRNA]
CTD
PMID:16684804
NCBI chr10:86,955,759...86,963,258
Ensembl chr10:86,958,599...86,963,258
G
SOX2
SRY-box transcription factor 2
decreases expression
EXP
vanadyl sulfate results in decreased expression of SOX2 mRNA
CTD
PMID:16330358
NCBI chr 3:181,711,925...181,714,436
Ensembl chr 3:181,711,925...181,714,436
G
SPP1
secreted phosphoprotein 1
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of SPP1 mRNA]
CTD
PMID:16684804
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
ST3GAL5
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of ST3GAL5 mRNA]
CTD
PMID:16684804
NCBI chr 2:85,837,120...85,889,034
Ensembl chr 2:85,837,120...85,905,199
G
STAT3
signal transducer and activator of transcription 3
increases expression
EXP
vanadyl sulfate results in increased expression of STAT3 mRNA
CTD
PMID:16330358
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,540
G
STAU2
staufen double-stranded RNA binding protein 2
decreases expression
EXP
vanadyl sulfate results in decreased expression of STAU2 mRNA
CTD
PMID:16330358
NCBI chr 8:73,420,369...73,747,480
Ensembl chr 8:73,420,369...73,747,708
G
STON1
stonin 1
increases expression
EXP
vanadyl sulfate results in increased expression of STON1 mRNA
CTD
PMID:16330358
NCBI chr 2:48,530,154...48,598,513
Ensembl chr 2:48,529,383...48,598,513
G
STX6
syntaxin 6
increases expression
EXP
vanadyl sulfate results in increased expression of STX6 mRNA
CTD
PMID:16330358
NCBI chr 1:180,972,725...181,022,870
Ensembl chr 1:180,972,712...181,023,121
G
TAF6L
TATA-box binding protein associated factor 6 like
decreases expression
EXP
vanadyl sulfate results in decreased expression of TAF6L mRNA
CTD
PMID:16330358
NCBI chr11:62,771,396...62,787,342
Ensembl chr11:62,771,357...62,787,342
G
TBX1
T-box transcription factor 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of TBX1 mRNA
CTD
PMID:16330358
NCBI chr22:19,756,703...19,783,593
Ensembl chr22:19,756,703...19,783,593
G
TERF2
telomeric repeat binding factor 2
decreases expression
EXP
vanadyl sulfate results in decreased expression of TERF2 mRNA
CTD
PMID:16330358
NCBI chr16:69,355,567...69,386,007
Ensembl chr16:69,355,567...69,408,571
G
THBS4
thrombospondin 4
multiple interactions
ISO
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of THBS4 mRNA]
CTD
PMID:16684804
NCBI chr 5:79,991,332...80,083,287
Ensembl chr 5:79,991,311...80,083,287
G
TIFA
TRAF interacting protein with forkhead associated domain
decreases expression
EXP
vanadyl sulfate results in decreased expression of TIFA mRNA
CTD
PMID:16330358
NCBI chr 4:112,274,537...112,285,904
Ensembl chr 4:112,272,968...112,285,955
G
TNFAIP3
TNF alpha induced protein 3
increases expression
EXP
vanadyl sulfate results in increased expression of TNFAIP3 mRNA
CTD
PMID:16330358
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
G
TOR2A
torsin family 2 member A
decreases expression
EXP
vanadyl sulfate results in decreased expression of TOR2A mRNA
CTD
PMID:16330358
NCBI chr 9:127,731,524...127,735,294
Ensembl chr 9:127,731,524...127,735,313
G
TPM1
tropomyosin 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of TPM1 mRNA
CTD
PMID:16330358
NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,620...63,071,915
G
TPP2
tripeptidyl peptidase 2
decreases expression
EXP
vanadyl sulfate results in decreased expression of TPP2 mRNA
CTD
PMID:16330358
NCBI chr13:102,596,986...102,679,958
Ensembl chr13:102,596,958...102,679,958
G
TREX1
three prime repair exonuclease 1
increases expression
EXP
vanadyl sulfate results in increased expression of TREX1 mRNA
CTD
PMID:16330358
NCBI chr 3:48,465,830...48,467,645
Ensembl chr 3:48,465,811...48,467,645
G
WARS2
tryptophanyl tRNA synthetase 2, mitochondrial
increases expression
EXP
vanadyl sulfate results in increased expression of WARS2 mRNA
CTD
PMID:16330358
NCBI chr 1:119,031,216...119,140,672
Ensembl chr 1:119,031,216...119,140,654
G
XAF1
XIAP associated factor 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of XAF1 mRNA
CTD
PMID:16330358
NCBI chr17:6,755,447...6,775,647
Ensembl chr17:6,755,447...6,775,647
G
ZBTB1
zinc finger and BTB domain containing 1
decreases expression
EXP
vanadyl sulfate results in decreased expression of ZBTB1 mRNA
CTD
PMID:16330358
NCBI chr14:64,503,716...64,533,693
Ensembl chr14:64,503,712...64,533,690
G
ZBTB24
zinc finger and BTB domain containing 24
decreases expression
EXP
vanadyl sulfate results in decreased expression of ZBTB24 mRNA
CTD
PMID:16330358
NCBI chr 6:109,462,594...109,483,219
Ensembl chr 6:109,460,632...109,483,239
G
ZDHHC21
zinc finger DHHC-type palmitoyltransferase 21
decreases expression
EXP
vanadyl sulfate results in decreased expression of ZDHHC21 mRNA
CTD
PMID:16330358
NCBI chr 9:14,588,797...14,693,432
Ensembl chr 9:14,611,071...14,693,432
G
ZFP30
ZFP30 zinc finger protein
decreases expression
EXP
vanadyl sulfate results in decreased expression of ZFP30 mRNA
CTD
PMID:16330358
NCBI chr19:37,631,006...37,656,261
Ensembl chr19:37,613,749...37,692,337
G
ZKSCAN3
zinc finger with KRAB and SCAN domains 3
increases expression
EXP
vanadyl sulfate results in increased expression of ZKSCAN3 mRNA
CTD
PMID:16330358
NCBI chr 6:28,349,878...28,369,172
Ensembl chr 6:28,349,947...28,369,172
G
ZNF436
zinc finger protein 436
decreases expression
EXP
vanadyl sulfate results in decreased expression of ZNF436 mRNA
CTD
PMID:16330358
NCBI chr 1:23,359,448...23,369,836
Ensembl chr 1:23,359,448...23,369,836
G
ZNF44
zinc finger protein 44
decreases expression
EXP
vanadyl sulfate results in decreased expression of ZNF44 mRNA
CTD
PMID:16330358
NCBI chr19:12,224,686...12,294,883
Ensembl chr19:12,224,686...12,294,883
G
ZNF503
zinc finger protein 503
decreases expression
EXP
vanadyl sulfate results in decreased expression of ZNF503 mRNA
CTD
PMID:16330358
NCBI chr10:75,279,725...75,401,916
Ensembl chr10:75,397,830...75,401,764
G
ZNF555
zinc finger protein 555
decreases expression
EXP
vanadyl sulfate results in decreased expression of ZNF555 mRNA
CTD
PMID:16330358
NCBI chr19:2,841,475...2,860,471
Ensembl chr19:2,841,437...2,860,471
G
ZNF823
zinc finger protein 823
decreases expression
EXP
vanadyl sulfate results in decreased expression of ZNF823 mRNA
CTD
PMID:16330358
NCBI chr19:11,721,265...11,738,946
Ensembl chr19:11,721,265...11,739,009
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all